Nevada 2023 2023 Regular Session

Nevada Senate Bill SB439 Introduced / Bill

                      
  
  	S.B. 439 
 
- 	*SB439* 
 
SENATE BILL NO. 439–SENATORS D. HARRIS,  
SCHEIBLE AND DONATE 
 
MARCH 27, 2023 
____________ 
 
Referred to Committee on Health and Human Services 
 
SUMMARY—Revises provisions relating to communicable 
diseases. (BDR 40-987) 
 
FISCAL NOTE: Effect on Local Government: May have Fiscal Impact. 
 Effect on the State: Yes. 
 
CONTAINS UNFUNDED MANDATE (§§ 1, 15, 44) 
(NOT REQUESTED BY AFFECTED LOCAL GOVERNMENT) 
 
~ 
 
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted. 
 
 
AN ACT relating to communicable diseases; requiring certain state 
and local agencies to develop policies to provide uninterrupted 
services during a public health emergency to certain persons; 
authorizing a person who has been convicted of certain crimes to 
petition a court to vacate the judgment and seal certain records; 
requiring a public or private detention facility to take certain 
measures to ensure the access of prisoners to treatment for and 
methods to prevent the acquisition of human immunodeficiency 
virus; revising provisions governing certain crimes committed by 
prisoners; requiring the board of trustees of a school district to 
establish a course or unit of a course of evidence-based, factual 
instruction in sexuality education; requiring certain public and 
private health insurers to provide certain coverage; requiring 
such an insurer to reimburse an advanced practice registered 
nurse or physician assistant at the same rate as a physician for 
certain services; imposing certain requirements relating to cost 
sharing for prescription drugs; authorizing providers of health 
care to receive credit toward requirements for continuing 
education for certain training relating to the human 
immunodeficiency virus; requiring certain providers of health 
care to complete such training; providing that the repeal or 
revision of certain crimes applies retroactively; and providing 
other matters properly relating thereto.   
 	– 2 – 
 
 
- 	*SB439* 
Legislative Counsel’s Digest: 
 Existing law requires the Division of Public and Behavioral Health of the 1 
Department of Health and Human Services and district, county and city health 2 
departments to perform certain functions relating to public health in this State, 3 
including certain duties relating to the control of communicable diseases. (NRS 4 
439.150-439.265, 439.340, 439.350, 439.360, 439.366, 439.367, 439.3675, 5 
439.405, 439.410, 439.460, 439.470) Existing law also requires a district health 6 
officer or the Chief Medical Officer to perform certain duties relating to the control 7 
of communicable diseases. (Chapter 441A of NRS) Existing law prescribes certain 8 
responsibilities of the Division of Health Care Financing and Policy of the 9 
Department concerning the administration of the Medicaid program. (NRS 10 
422.061, 422.063) Section 1 of this bill requires the Department and all district, 11 
county and city boards of health to develop policies to provide uninterrupted 12 
services during a public health emergency to persons who have been diagnosed 13 
with the human immunodeficiency virus or persons who are at a high risk of 14 
acquiring the human immunodeficiency virus. Section 2 of this bill makes a 15 
conforming change to indicate the proper placement of section 1 in the Nevada 16 
Revised Statutes. 17 
 Senate Bill No. 275 of the 2021 Legislative Session repealed certain criminal 18 
offenses for which an element of the offense was having the human 19 
immunodeficiency virus. (Section 24, chapter 491, Statutes of Nevada 2021, at 20 
page 3199) Section 77 of this bill provides that the repeal of those offenses applies 21 
retroactively to violations that occurred before the effective date of Senate Bill No. 22 
275. Section 3 of this bill authorizes a person who was convicted of such an 23 
offense before the effective date of Senate Bill No. 275 to petition the court in 24 
which he or she was convicted for an order vacating the judgment and sealing 25 
certain records relating to the conviction. Section 3: (1) requires the court to grant 26 
the petition if the petition meets the relevant statutory requirements; and (2) 27 
authorizes the court to issue an order to vacate the judgment and dismiss the 28 
accusatory pleading if the petition is deficient with respect to the sealing of  29 
the records but the petitioner otherwise satisfies the requirements for vacating the 30 
judgment. Section 4 of this bill makes a conforming change to indicate the proper 31 
placement of section 3 in the Nevada Revised Statutes. Sections 5-7 of this bill 32 
exempt a petition filed pursuant to section 3 from certain requirements, and 33 
sections 8-10 of this bill make various changes to ensure that an order issued 34 
pursuant to section 3 is treated in the same manner as other similar orders for 35 
certain purposes. 36 
 Existing law requires the Director of the Department of Corrections to establish 37 
standards for the medical and dental services of each institution or facility under the 38 
control of the Department. (NRS 209.381) Existing law also requires a sheriff, chief 39 
of police or town marshal to arrange for the administration of medical care required 40 
by prisoners while in his or her custody. (NRS 211.140) Sections 11 and 12 of this 41 
bill impose certain requirements on the operators of public and private prisons, jails 42 
and detention facilities to ensure the access of prisoners to treatment for human 43 
immunodeficiency virus and methods of preventing the acquisition of human 44 
immunodeficiency virus. 45 
 Existing law prohibits a prisoner from using, propelling, discharging, spreading 46 
or concealing human excrement or bodily fluid with intent or under circumstances 47 
where it is reasonably likely that the excrement or fluid will come in contact with 48 
another person. Under most circumstances, a violation is a gross misdemeanor or a 49 
category D felony, depending on the circumstances of the prisoner’s confinement. 50 
However, if the prisoner knew at the time of the offense that any portion of the 51 
excrement or bodily fluid contained a communicable disease that causes or is 52 
reasonably likely to cause substantial bodily harm, the violation is a category A 53 
felony, regardless of whether the communicable disease was transmitted.  54   
 	– 3 – 
 
 
- 	*SB439* 
(NRS 212.189) Section 13 of this bill instead provides that such a violation is only 55 
a category A felony where: (1) the prisoner knew the communicable disease was 56 
likely to be transmitted by his or her conduct; and (2) the communicable disease 57 
was actually transmitted as a result of the conduct. Section 78 of this bill provides 58 
that the provisions of section 13 apply retroactively to violations that occurred 59 
before the effective date of that section, if the person who committed the violation 60 
has not been convicted before that date. 61 
 Existing law requires public and private health plans, including Medicaid and 62 
health plans for state and local government employees, to cover an examination and 63 
testing of a pregnant woman for Chlamydia trachomatis, gonorrhea, hepatitis B, 64 
hepatitis C and syphilis. (NRS 287.010, 287.04335, 422.27173, 689A.0412, 65 
689B.0315, 689C.1675, 695A.1856, 695B.1913, 695C.1737, 695G.1714) Sections 66 
15, 16, 23, 34, 42, 47, 52, 55, 60, 65, 67 and 72 of this bill additionally require 67 
such insurance plans to cover: (1) testing for, treatment of and prevention of 68 
sexually transmitted diseases; and (2) condoms for covered persons who are 13 69 
years of age or older. Sections 15, 16, 22, 35, 43, 48, 52, 56, 61, 66, 67 and 73 of 70 
this bill require an insurer to count any amount paid by a covered person or another 71 
person or entity on behalf of a covered person toward any cost sharing requirement 72 
applicable to certain prescription drugs, including drugs to prevent human 73 
immunodeficiency virus, treat human immunodeficiency virus or hepatitis C or 74 
provide certain treatment for substance use disorder. Section 21 of this bill defines 75 
the term “pharmacy benefit manager” for the purpose of provisions of law 76 
governing Medicaid coverage of prescription drugs. 77 
 Existing law requires public and private health plans, including Medicaid and 78 
health plans for state and local government employees, to cover drugs that prevent 79 
the acquisition of human immunodeficiency virus and any related laboratory or 80 
diagnostic procedures. (NRS 287.010, 287.04335, 422.27235, 422.4025, 81 
689A.0437, 689B.0312, 689C.1671, 695A.1843, 695B.1924, 695C.1743, 82 
695G.1705) Sections 26, 31, 37, 44, 51, 57, 62, 68 and 74 of this bill require such 83 
insurance plans to cover all such drugs approved by the United States Food and 84 
Drug Administration and all drugs approved by the Food and Drug Administration 85 
for treating human immunodeficiency virus or hepatitis C without restrictions, other 86 
than step therapy. Sections 24, 37, 44, 51, 57, 62, 68 and 74 of this bill require 87 
such insurance plans to: (1) cover any service to test for, prevent or treat those 88 
diseases provided by a provider of primary care if the service is covered when 89 
provided by a specialist and certain other requirements are met; and (2) reimburse 90 
an advanced practice registered nurse or a physician assistant for such services at a 91 
rate equal to that provided to a physician. Sections 15, 16, 20, 26, 31, 33, 41, 46, 92 
52, 54, 59, 64, 67 and 71 impose similar requirements regarding: (1) coverage of 93 
certain drugs approved by the Food and Drug Administration to treat substance use 94 
disorder; (2) coverage of services for the treatment of substance use disorder 95 
provided by a provider of primary care; and (3) reimbursement for such services 96 
provided by an advanced practice registered nurse. Sections 36, 38, 49 and 50 of 97 
this bill make conforming changes to indicate that the coverage required by 98 
sections 33 and 46 is in addition to certain coverage of services for the treatment of 99 
substance use disorder that certain insurers are required by existing law to provide. 100 
Sections 14, 25 and 39 of this bill make conforming changes to indicate the proper 101 
placement of sections 20-22 and 33-35 in the Nevada Revised Statutes. Section 69 102 
of this bill authorizes the Commissioner of Insurance to suspend or revoke the 103 
certificate of a health maintenance organization that fails to comply with the 104 
requirements of sections 64-66. The Commissioner would also be authorized to 105 
take such action against any health insurer who fails to comply with the 106 
requirements of sections 33-35, 37, 41-44, 46-48, 50, 54-57, 59-62, 67, 68 or 71-74 107 
of this bill. (NRS 680A.200, 695C.330) 108   
 	– 4 – 
 
 
- 	*SB439* 
 Existing law requires the board of trustees of each school district to establish a 109 
course or unit of a course of instruction concerning acquired immune deficiency 110 
syndrome, the human reproductive system, related communicable diseases and 111 
sexual responsibility which must be taught by a teacher or school nurse whose 112 
qualifications have been approved by the board of trustees. (NRS 389.036) Section 113 
17 of this bill instead requires the board of trustees of a school district to establish a 114 
course or unit of a course of evidence-based, factual instruction in sexuality 115 
education. Section 17 additionally authorizes a provider of health care or other 116 
qualified person approved by the board of trustees to teach such a course. Section 117 
18 of this bill requires the standards adopted by the Council to Establish Academic 118 
Standards for Public Schools for instruction in health to include standards for 119 
sexuality education. Section 18 also authorizes the Council to include topics related 120 
to sexuality education in the standards for other courses where appropriate. 121 
 Existing law requires physicians, osteopathic physicians, physician assistants 122 
and nurses to complete certain continuing education in order to renew their 123 
licenses. (NRS 630.253, 632.343, 633.471) Sections 28-30 and 75 of this bill 124 
require such a provider of health care who provides or supervises the provision of 125 
emergency medical care or primary care in a hospital to complete before the first 126 
renewal of their license or, for currently practicing providers, the next renewal of 127 
their license, at least 2 hours of training in stigma, discrimination and unrecognized 128 
bias toward persons who have acquired or are at a high risk of acquiring human 129 
immunodeficiency virus. Section 27 of this bill authorizes any provider of health 130 
care to use training in that subject in place of not more than 2 hours of any other 131 
training that the provider is required to complete, other than continuing education 132 
relating to ethics. 133 
 
 
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN 
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: 
 
 Section 1.  Chapter 441A of NRS is hereby amended by 1 
adding thereto a new section to read as follows: 2 
 1. The Department of Health and Human Services and all 3 
district, county and city boards of health shall develop policies to 4 
provide uninterrupted services during a public health emergency 5 
to persons who have been diagnosed with the human 6 
immunodeficiency virus or who are at a high risk of acquiring the 7 
human immunodeficiency virus and who are receiving services 8 
from the Department or any division thereof or the district, county 9 
or city health department, as applicable. Such policies may 10 
provide, without limitation, for the delivery of such services during 11 
a public health emergency: 12 
 (a) Over the Internet; 13 
 (b) Using an application for a mobile device; or 14 
 (c) By calling or sending text messages from a telephone 15 
number that is not generally blocked or identified as a source of 16 
unwanted calls or messages. 17 
 2. As used in this section: 18 
 (a) “Mobile device” includes, without limitation, a smartphone 19 
or a tablet computer. 20   
 	– 5 – 
 
 
- 	*SB439* 
 (b) “Public health emergency” means: 1 
  (1) A public health emergency or other health event 2 
identified by a health authority pursuant to NRS 439.970; or 3 
  (2) A state of emergency or declaration of disaster 4 
proclaimed pursuant to NRS 414.070 that relates to or affects 5 
public health. 6 
 Sec. 2.  NRS 441A.334 is hereby amended to read as follows: 7 
 441A.334 As used in this section and NRS 441A.335 and 8 
441A.336, and section 1 of this act, “provider of health care” means 9 
a physician, nurse or physician assistant licensed in accordance with 10 
state law. 11 
 Sec. 3.  Chapter 179 of NRS is hereby amended by adding 12 
thereto a new section to read as follows: 13 
 1. If a person has been convicted of a violation of NRS 14 
201.205 or 201.358, as those sections existed before June 6, 2021, 15 
which is the effective date of repeal of those sections by section 24 16 
of chapter 491, Statutes of Nevada 2021, at page 3199, the person 17 
may petition the court in which he or she was convicted for an 18 
order: 19 
 (a) Vacating the judgment; and 20 
 (b) Sealing all documents, papers and exhibits in the person’s 21 
record, minute book entries and entries on dockets, and other 22 
documents relating to the case in the custody of such other 23 
agencies and officers as are named in the court’s order. 24 
 2. A petition filed pursuant to subsection 1 must satisfy the 25 
requirements of NRS 179.245. 26 
 3. Except as otherwise provided in subsection 6, the court 27 
shall grant a petition filed pursuant to subsection 1 if the petition 28 
meets the requirements of this section. 29 
 4. If the court grants a petition filed pursuant to subsection 1, 30 
the court shall: 31 
 (a) Vacate the judgment and dismiss the accusatory pleading; 32 
and 33 
 (b) Order sealed all documents, papers and exhibits in the 34 
petitioner’s record, minute book entries and entries on dockets and 35 
other documents relating to the case in the custody of such other 36 
agencies and officers as are named in the court’s order.  37 
 5. If a petition filed pursuant to subsection 1 does not satisfy 38 
the requirements of NRS 179.245 or the court determines that  39 
the petition is otherwise deficient with respect to the sealing of the 40 
petitioner’s record, the court may enter an order to vacate the 41 
judgment and dismiss the accusatory pleading if the petitioner 42 
satisfies all requirements necessary for the judgment to be vacated. 43 
 6. If the court enters an order pursuant to subsection 5, the 44 
court shall also order sealed the records of the petitioner which 45   
 	– 6 – 
 
 
- 	*SB439* 
relate to the judgment being vacated in accordance with 1 
paragraph (b) of subsection 4, regardless of whether any records 2 
relating to other convictions are ineligible for sealing, either by 3 
operation of law or because of a deficiency in the petition. 4 
 7. No fee may be charged by any court or agency of criminal 5 
justice for the submission of a petition pursuant to this section. 6 
 Sec. 4.  NRS 179.241 is hereby amended to read as follows: 7 
 179.241 As used in NRS 179.2405 to 179.301, inclusive, and 8 
section 3 of this act, unless the context otherwise requires, the 9 
words and terms defined in NRS 179.242, 179.243 and 179.244 10 
have the meanings ascribed to them in those sections. 11 
 Sec. 5.  NRS 179.245 is hereby amended to read as follows: 12 
 179.245 1.  Except as otherwise provided in subsection 6 and 13 
NRS 176.211, 176A.245, 176A.265, 176A.295, 179.247, 179.259, 14 
201.354 and 453.3365 [,] and section 3 of this act, a person may 15 
petition the court in which the person was convicted for the sealing 16 
of all records relating to a conviction of: 17 
 (a) A category A felony, a crime of violence or residential 18 
burglary pursuant to NRS 205.060 after 10 years from the date of 19 
release from actual custody or discharge from parole or probation, 20 
whichever occurs later; 21 
 (b) Except as otherwise provided in paragraphs (a) and (e), a 22 
category B, C or D felony after 5 years from the date of release from 23 
actual custody or discharge from parole or probation, whichever 24 
occurs later; 25 
 (c) A category E felony after 2 years from the date of release 26 
from actual custody or discharge from parole or probation, 27 
whichever occurs later; 28 
 (d) Except as otherwise provided in paragraph (e), any gross 29 
misdemeanor after 2 years from the date of release from actual 30 
custody or discharge from probation, whichever occurs later; 31 
 (e) A violation of NRS 422.540 to 422.570, inclusive, a 32 
violation of NRS 484C.110 or 484C.120 other than a felony, or a 33 
battery which constitutes domestic violence pursuant to NRS 33.018 34 
other than a felony, after 7 years from the date of release from actual 35 
custody or from the date when the person is no longer under a 36 
suspended sentence, whichever occurs later;  37 
 (f) Except as otherwise provided in paragraph (e), if the offense 38 
is punished as a misdemeanor, a battery pursuant to NRS 200.481, 39 
harassment pursuant to NRS 200.571, stalking pursuant to NRS 40 
200.575 or a violation of a temporary or extended order for 41 
protection, after 2 years from the date of release from actual custody 42 
or from the date when the person is no longer under a suspended 43 
sentence, whichever occurs later; or 44   
 	– 7 – 
 
 
- 	*SB439* 
 (g) Any other misdemeanor after 1 year from the date of release 1 
from actual custody or from the date when the person is no longer 2 
under a suspended sentence, whichever occurs later. 3 
 2.  A petition filed pursuant to subsection 1 must: 4 
 (a) Be accompanied by the petitioner’s current, verified records 5 
received from the Central Repository for Nevada Records of 6 
Criminal History; 7 
 (b) If the petition references NRS 453.3365, include a certificate 8 
of acknowledgment or the disposition of the proceedings for the 9 
records to be sealed from all agencies of criminal justice which 10 
maintain such records; 11 
 (c) Include a list of any other public or private agency, company, 12 
official or other custodian of records that is reasonably known to the 13 
petitioner to have possession of records of the conviction and to 14 
whom the order to seal records, if issued, will be directed; and 15 
 (d) Include information that, to the best knowledge and belief of 16 
the petitioner, accurately and completely identifies the records to be 17 
sealed, including, without limitation, the: 18 
  (1) Date of birth of the petitioner; 19 
  (2) Specific conviction to which the records to be sealed 20 
pertain; and 21 
  (3) Date of arrest relating to the specific conviction to which 22 
the records to be sealed pertain. 23 
 3.  Upon receiving a petition pursuant to this section, the court 24 
shall notify the law enforcement agency that arrested the petitioner 25 
for the crime and the prosecuting attorney, including, without 26 
limitation, the Attorney General, who prosecuted the petitioner for 27 
the crime. The prosecuting attorney and any person having relevant 28 
evidence may testify and present evidence at any hearing on the 29 
petition. 30 
 4.  If the prosecuting agency that prosecuted the petitioner for 31 
the crime stipulates to the sealing of the records, the court shall 32 
apply the presumption set forth in NRS 179.2445 and seal the 33 
records. If the prosecuting agency does not stipulate to the sealing of 34 
the records or does not file a written objection within 30 days after 35 
receiving notification pursuant to subsection 3 and the court makes 36 
the findings set forth in subsection 5, the court may order the sealing 37 
of the records in accordance with subsection 5 without a hearing. If 38 
the court does not order the sealing of the records or the prosecuting 39 
agency files a written objection, a hearing on the petition must be 40 
conducted. At the hearing, unless an objecting party presents 41 
evidence sufficient to rebut the presumption set forth in NRS 42 
179.2445, the court shall apply the presumption and seal the records.  43 
 5. If the court finds that, in the period prescribed in subsection 44 
1, the petitioner has not been charged with any offense for which the 45   
 	– 8 – 
 
 
- 	*SB439* 
charges are pending or convicted of any offense, except for minor 1 
moving or standing traffic violations, the court may order sealed all 2 
records of the conviction which are in the custody of any agency of 3 
criminal justice or any public or private agency, company, official 4 
or other custodian of records in the State of Nevada, and may also 5 
order all such records of the petitioner returned to the file of the 6 
court where the proceeding was commenced from, including, 7 
without limitation, the Federal Bureau of Investigation and all other 8 
agencies of criminal justice which maintain such records and which 9 
are reasonably known by either the petitioner or the court to have 10 
possession of such records. 11 
 6.  A person may not petition the court to seal records relating 12 
to a conviction of: 13 
 (a) A crime against a child; 14 
 (b) A sexual offense; 15 
 (c) Invasion of the home with a deadly weapon pursuant to  16 
NRS 205.067; 17 
 (d) A violation of NRS 484C.110 or 484C.120 that is punishable 18 
as a felony pursuant to paragraph (c) of subsection 1 of  19 
NRS 484C.400; 20 
 (e) A violation of NRS 484C.430; 21 
 (f) A homicide resulting from driving or being in actual physical 22 
control of a vehicle while under the influence of intoxicating liquor 23 
or a controlled substance or resulting from any other conduct 24 
prohibited by NRS 484C.110, 484C.130 or 484C.430; 25 
 (g) A violation of NRS 488.410 that is punishable as a felony 26 
pursuant to NRS 488.427; or 27 
 (h) A violation of NRS 488.420 or 488.425. 28 
 7.  The provisions of paragraph (e) of subsection 1 and 29 
paragraph (d) of subsection 6 must not be construed to preclude a 30 
person from being able to petition the court to seal records relating 31 
to a conviction for a violation of NRS 484C.110 or 484C.120 32 
pursuant to this section if the person was found guilty of a violation 33 
of NRS 484C.110 or 484C.120 that is punishable pursuant to: 34 
 (a) Paragraph (b) of subsection 1 of NRS 484C.400; or 35 
 (b) Paragraph (c) of subsection 1 of NRS 484C.400 but had a 36 
judgment of conviction entered against him or her for a violation of 37 
paragraph (b) of subsection 1 of NRS 484C.400 because the person 38 
participated in the statewide sobriety and drug monitoring program 39 
established pursuant to NRS 484C.392. 40 
 8.  If the court grants a petition for the sealing of records 41 
pursuant to this section, upon the request of the person whose 42 
records are sealed, the court may order sealed all records of the civil 43 
proceeding in which the records were sealed. 44 
 9.  As used in this section: 45   
 	– 9 – 
 
 
- 	*SB439* 
 (a) “Crime against a child” has the meaning ascribed to it in 1 
NRS 179D.0357. 2 
 (b) “Sexual offense” means: 3 
  (1) Murder of the first degree committed in the perpetration 4 
or attempted perpetration of sexual assault or of sexual abuse or 5 
sexual molestation of a child less than 14 years of age pursuant to 6 
paragraph (b) of subsection 1 of NRS 200.030. 7 
  (2) Sexual assault pursuant to NRS 200.366. 8 
  (3) Statutory sexual seduction pursuant to NRS 200.368, if 9 
punishable as a felony. 10 
  (4) Battery with intent to commit sexual assault pursuant to 11 
NRS 200.400. 12 
  (5) An offense involving the administration of a drug to 13 
another person with the intent to enable or assist the commission of 14 
a felony pursuant to NRS 200.405, if the felony is an offense listed 15 
in this paragraph. 16 
  (6) An offense involving the administration of a controlled 17 
substance to another person with the intent to enable or assist the 18 
commission of a crime of violence, if the crime of violence is an 19 
offense listed in this paragraph. 20 
  (7) Abuse of a child pursuant to NRS 200.508, if the abuse 21 
involved sexual abuse or sexual exploitation. 22 
  (8) An offense involving pornography and a minor pursuant 23 
to NRS 200.710 to 200.730, inclusive. 24 
  (9) Incest pursuant to NRS 201.180. 25 
  (10) Open or gross lewdness pursuant to NRS 201.210, if 26 
punishable as a felony. 27 
  (11) Indecent or obscene exposure pursuant to NRS 201.220, 28 
if punishable as a felony. 29 
  (12) Lewdness with a child pursuant to NRS 201.230. 30 
  (13) Sexual penetration of a dead human body pursuant to 31 
NRS 201.450. 32 
  (14) Sexual conduct between certain employees of a school 33 
or volunteers at a school and a pupil pursuant to NRS 201.540. 34 
  (15) Sexual conduct between certain employees of a college 35 
or university and a student pursuant to NRS 201.550. 36 
  (16) Luring a child or a person with mental illness pursuant 37 
to NRS 201.560, if punishable as a felony. 38 
  (17) An attempt to commit an offense listed in this 39 
paragraph. 40 
 Sec. 6.  NRS 179.2595 is hereby amended to read as follows: 41 
 179.2595 Notwithstanding the procedure established in NRS 42 
179.245, 179.255 or 179.259 or section 3 of this act for the filing of 43 
a petition for the sealing of records: 44   
 	– 10 – 
 
 
- 	*SB439* 
 1. If a person wishes to have more than one record sealed and 1 
would otherwise need to file a petition in more than one court for 2 
the sealing of the records, the person may, instead of filing a petition 3 
in each court, file a petition in district court for the sealing of all 4 
such records. 5 
 2. If a person files a petition for the sealing of records in 6 
district court pursuant to subsection 1 or NRS 179.245, 179.255 or 7 
179.259, the district court may order the sealing of any other records 8 
in the justice or municipal courts in accordance with the provisions 9 
of NRS 179.2405 to 179.301, inclusive. 10 
 3.  A district court shall act in accordance with subsection 2 11 
regardless of whether a petition filed pursuant to this section 12 
includes a request for the sealing of a record in a district court. 13 
 Sec. 7.  NRS 179.271 is hereby amended to read as follows: 14 
 179.271 1. Except as otherwise provided in this section [,] 15 
and section 3 of this act, if an offense is decriminalized: 16 
 (a) Any person who was convicted of that offense before the 17 
date on which the offense was decriminalized may submit a written 18 
request to any court in which the person was convicted of that 19 
offense for the sealing of any record of criminal history in its 20 
possession and in the possession of any agency of criminal justice 21 
relating to the conviction.  22 
 (b) Upon receipt of a request pursuant to paragraph (a), the court 23 
shall, as soon as practicable, send written notice of the request to the 24 
office of the prosecuting attorney that prosecuted the offense. If the 25 
office of the prosecuting attorney objects to the granting of  26 
the request, a written objection to the request must be filed with the 27 
court within 10 judicial days after the date on which notice of the 28 
request was received. If no written objection to the request is filed, 29 
the court shall grant the request. If a written objection to the request 30 
is filed, the court must hold a hearing on the request. At the hearing, 31 
the court shall grant the request unless the prosecuting attorney 32 
establishes, by clear and convincing evidence, that there is good 33 
cause not to grant the request. The decision of the court to deny the 34 
request is subject to appeal. 35 
 2. No fee may be charged by any court or agency of criminal 36 
justice for the submission of a request pursuant to this section. 37 
 3. The provisions of this section do not apply to a traffic 38 
offense. 39 
 4. As used in this section: 40 
 (a) “Decriminalized” means that an offense is no longer 41 
punishable as a crime as the result of enactment of an act of the 42 
Legislature or the passage of a referendum petition or initiative 43 
petition pursuant to Article 19 of the Nevada Constitution. 44   
 	– 11 – 
 
 
- 	*SB439* 
 (b) “Traffic offense” means a violation of any state or local law 1 
or ordinance governing the operation of a motor vehicle upon any 2 
highway within this State. 3 
 Sec. 8.  NRS 179.275 is hereby amended to read as follows: 4 
 179.275 Where the court orders the sealing of a record 5 
pursuant to NRS 34.970, 174.034, 176.211, 176A.245, 176A.265, 6 
176A.295, 179.245, 179.247, 179.255, 179.259, 179.2595, 179.271, 7 
201.354 or 453.3365, or section 3 of this act, a copy of the order 8 
must be sent to: 9 
 1.  The Central Repository for Nevada Records of Criminal 10 
History; and 11 
 2.  Each agency of criminal justice and each public or private 12 
company, agency, official or other custodian of records named in 13 
the order, and that person shall seal the records in his or her custody 14 
which relate to the matters contained in the order, shall advise the 15 
court of compliance and shall then seal the order. 16 
 Sec. 9.  NRS 179.285 is hereby amended to read as follows: 17 
 179.285 Except as otherwise provided in NRS 179.301: 18 
 1.  If the court orders a record sealed pursuant to NRS 34.970, 19 
174.034, 176.211, 176A.245, 176A.265, 176A.295, 179.245, 20 
179.247, 179.255, 179.259, 179.2595, 179.271, 201.354 or 21 
453.3365 [:] or section 3 of this act: 22 
 (a) All proceedings recounted in the record are deemed never to 23 
have occurred, and the person to whom the order pertains may 24 
properly answer accordingly to any inquiry, including, without 25 
limitation, an inquiry relating to an application for employment, 26 
concerning the arrest, conviction, dismissal or acquittal and the 27 
events and proceedings relating to the arrest, conviction, dismissal 28 
or acquittal. 29 
 (b) The person is immediately restored to the following civil 30 
rights if the person’s civil rights previously have not been restored: 31 
  (1) The right to vote; 32 
  (2) The right to hold office; and 33 
  (3) The right to serve on a jury. 34 
 2.  Upon the sealing of the person’s records, a person who is 35 
restored to his or her civil rights pursuant to subsection 1 must be 36 
given: 37 
 (a) An official document which demonstrates that the person has 38 
been restored to the civil rights set forth in paragraph (b) of 39 
subsection 1; and 40 
 (b) A written notice informing the person that he or she has not 41 
been restored to the right to bear arms, unless the person has 42 
received a pardon and the pardon does not restrict his or her right to 43 
bear arms. 44   
 	– 12 – 
 
 
- 	*SB439* 
 3.  A person who has had his or her records sealed in this State 1 
or any other state and whose official documentation of the 2 
restoration of civil rights is lost, damaged or destroyed may file a 3 
written request with a court of competent jurisdiction to restore his 4 
or her civil rights pursuant to this section. Upon verification that the 5 
person has had his or her records sealed, the court shall issue an 6 
order restoring the person to the civil rights to vote, to hold office 7 
and to serve on a jury. A person must not be required to pay a fee to 8 
receive such an order. 9 
 4.  A person who has had his or her records sealed in this State 10 
or any other state may present official documentation that the person 11 
has been restored to his or her civil rights or a court order restoring 12 
civil rights as proof that the person has been restored to the right to 13 
vote, to hold office and to serve as a juror. 14 
 Sec. 10.  NRS 179.295 is hereby amended to read as follows: 15 
 179.295 1.  The person who is the subject of the records that 16 
are sealed pursuant to NRS 34.970, 174.034, 176.211, 176A.245, 17 
176A.265, 176A.295, 179.245, 179.247, 179.255, 179.259, 18 
179.2595, 179.271, 201.354 or 453.3365 or section 3 of this act 19 
may petition the court that ordered the records sealed to permit 20 
inspection of the records by a person named in the petition, and the 21 
court may order such inspection. Except as otherwise provided in 22 
this section, subsection 9 of NRS 179.255 and NRS 179.259 and 23 
179.301, the court may not order the inspection of the records under 24 
any other circumstances. 25 
 2.  If a person has been arrested, the charges have been 26 
dismissed and the records of the arrest have been sealed, the court 27 
may order the inspection of the records by a prosecuting attorney 28 
upon a showing that as a result of newly discovered evidence, the 29 
person has been arrested for the same or a similar offense and that 30 
there is sufficient evidence reasonably to conclude that the person 31 
will stand trial for the offense. 32 
 3.  The court may, upon the application of a prosecuting 33 
attorney or an attorney representing a defendant in a criminal action, 34 
order an inspection of such records for the purpose of obtaining 35 
information relating to persons who were involved in the incident 36 
recorded. 37 
 4.  This section does not prohibit a court from considering a 38 
proceeding for which records have been sealed pursuant to NRS 39 
174.034, 176.211, 176A.245, 176A.265, 176A.295, 179.245, 40 
179.247, 179.255, 179.259, 179.2595, 179.271, 201.354 or 41 
453.3365 or section 3 of this act in determining whether to grant a 42 
petition pursuant to NRS 176.211, 176A.245, 176A.265, 176A.295, 43 
179.245, 179.255, 179.259, 179.2595 or 453.3365 for a conviction 44 
of another offense. 45   
 	– 13 – 
 
 
- 	*SB439* 
 Sec. 11.  Chapter 209 of NRS is hereby amended by adding 1 
thereto a new section to read as follows: 2 
 1. The Department or the operator of a private facility or 3 
institution shall not enter into a contract or other agreement with 4 
any person or entity to provide medical services to offenders who 5 
are diagnosed with human immunodeficiency virus unless the 6 
person or entity demonstrates that at least 95 percent of the 7 
patients who are diagnosed with human immunodeficiency virus 8 
to whom the person or entity provides medical services: 9 
 (a) Are offered treatment on the same day as the diagnosis; 10 
and 11 
 (b) Are able to begin such treatment not later than 7 days after 12 
diagnosis. 13 
 2. Except as otherwise provided in subsection 3, an 14 
institution, facility or private facility or institution shall take 15 
reasonable measures to ensure the availability of:  16 
 (a) Any drug prescribed for treating the human 17 
immunodeficiency virus in the form recommended by the 18 
prescribing practitioner to each offender who has been diagnosed 19 
with human immunodeficiency virus to the same extent and under 20 
the same conditions as other medical care for offenders. 21 
 (b) Methods of preventing the acquisition of human 22 
immunodeficiency virus, including, without limitation, drugs 23 
approved by the United States Food and Drug Administration for 24 
that purpose and condoms, to all offenders free of charge. 25 
 3. An institution, facility or private facility or institution: 26 
 (a) Is not required to make available a drug described in 27 
subsection 2 for which a prescription is required to an offender for 28 
whom such a prescription has not been issued. 29 
 (b) Shall take reasonable measures to make available to all 30 
offenders a provider of health care who is authorized to issue a 31 
prescription for a drug described in subsection 2. 32 
 (c) Shall not demand, request or suggest that a provider of 33 
health care refrain from issuing a prescription for a drug 34 
described in subsection 2 to an offender or take any other measure 35 
to prevent a provider of health care from issuing such a 36 
prescription. 37 
 4. As used in this section, “provider of health care” has the 38 
meaning ascribed to it in NRS 629.031. 39 
 Sec. 12.  Chapter 211 of NRS is hereby amended by adding 40 
thereto a new section to read as follows: 41 
 1. A sheriff, chief of police or town marshal who is 42 
responsible for a county, city or town jail or detention facility shall 43 
not enter into a contract or other agreement with any person or 44 
entity to provide medical services to prisoners who are diagnosed 45   
 	– 14 – 
 
 
- 	*SB439* 
with human immunodeficiency virus unless the person or entity 1 
demonstrates that at least 95 percent of the patients who are 2 
diagnosed with human immunodeficiency virus to whom the 3 
person or entity provides medical services: 4 
 (a) Are offered treatment on the same day as the diagnosis; 5 
and 6 
 (b) Are able to begin such treatment not later than 7 days after 7 
diagnosis. 8 
 2. Except as otherwise provided in subsection 3, a county, city 9 
or town jail or detention facility shall take reasonable measures to 10 
ensure the availability of:  11 
 (a) Any drug prescribed for treating the human 12 
immunodeficiency virus in the form recommended by the 13 
prescribing practitioner to each prisoner who has been diagnosed 14 
with human immunodeficiency virus to the same extent and under 15 
the same conditions as other medical care for prisoners. 16 
 (b) Methods of preventing the acquisition of human 17 
immunodeficiency virus, including, without limitation, drugs 18 
approved by the United States Food and Drug Administration for 19 
that purpose and condoms, to all prisoners free of charge. 20 
 3. A county, city or town jail or detention facility: 21 
 (a) Is not required to make available a drug described in 22 
subsection 2 for which a prescription is required to a prisoner for 23 
whom such a prescription has not been issued. 24 
 (b) Shall take reasonable measures to make available to all 25 
prisoners a provider of health care who is authorized to issue a 26 
prescription for a drug described in subsection 2. 27 
 (c) Shall not demand, request or suggest that a provider of 28 
health care refrain from issuing a prescription for a drug 29 
described in subsection 2 to an offender or take any other measure 30 
to prevent a provider of health care from issuing such a 31 
prescription. 32 
 4. As used in this section, “provider of health care” has the 33 
meaning ascribed to it in NRS 629.031. 34 
 Sec. 13.  NRS 212.189 is hereby amended to read as follows: 35 
 212.189 1.  Except as otherwise provided in subsection 10, a 36 
prisoner who is under lawful arrest, in lawful custody or in lawful 37 
confinement shall not knowingly: 38 
 (a) Store or stockpile any human excrement or bodily fluid; 39 
 (b) Sell, supply or provide any human excrement or bodily fluid 40 
to any other person; 41 
 (c) Buy, receive or acquire any human excrement or bodily fluid 42 
from any other person; or 43   
 	– 15 – 
 
 
- 	*SB439* 
 (d) Use, propel, discharge, spread or conceal, or cause to be 1 
used, propelled, discharged, spread or concealed, any human 2 
excrement or bodily fluid: 3 
  (1) With the intent to have the excrement or bodily fluid 4 
come into physical contact with any portion of the body of another 5 
person, including, without limitation, an officer or employee of a 6 
prison or law enforcement agency, whether or not such physical 7 
contact actually occurs; or 8 
  (2) Under circumstances in which the excrement or bodily 9 
fluid is reasonably likely to come into physical contact with any 10 
portion of the body of another person, including, without limitation, 11 
an officer or employee of a prison or law enforcement agency, 12 
whether or not such physical contact actually occurs. 13 
 2.  Except as otherwise provided in subsection 4, if a prisoner 14 
who is under lawful arrest or in lawful custody violates any 15 
provision of subsection 1, the prisoner is guilty of: 16 
 (a) For a first offense, a gross misdemeanor. 17 
 (b) For a second offense or any subsequent offense, a category 18 
D felony and shall be punished as provided in NRS 193.130. 19 
 3.  Except as otherwise provided in subsection 4, if a prisoner 20 
who is in lawful confinement, other than residential confinement, 21 
violates any provision of subsection 1, the prisoner is guilty of a 22 
category B felony and shall be punished by imprisonment in the 23 
state prison for a minimum term of not less than 2 years and a 24 
maximum term of not more than 10 years, and may be further 25 
punished by a fine of not more than $10,000. 26 
 4.  If a prisoner who is under lawful arrest, in lawful custody or 27 
in lawful confinement violates any provision of paragraph (d) of 28 
subsection 1 and, at the time of the offense, the prisoner knew that 29 
any portion of the excrement or bodily fluid involved in the offense 30 
contained a communicable disease that causes or is reasonably 31 
likely to cause substantial bodily harm [, whether or not] and is 32 
likely to be transmitted as a result of the offense and the 33 
communicable disease was transmitted to a victim as a result of the 34 
offense, the prisoner is guilty of a category A felony and shall be 35 
punished by imprisonment in the state prison: 36 
 (a) For life with the possibility of parole, with eligibility for 37 
parole beginning when a minimum of 10 years has been served; or 38 
 (b) For a definite term of 25 years, with eligibility for parole 39 
beginning when a minimum of 10 years has been served, 40 
 and may be further punished by a fine of not more than $50,000. 41 
 5.  A sentence imposed upon a prisoner pursuant to subsection 42 
2, 3 or 4: 43 
 (a) Is not subject to suspension or the granting of probation; and 44   
 	– 16 – 
 
 
- 	*SB439* 
 (b) Must run consecutively after the prisoner has served any 1 
sentences imposed upon the prisoner for the offense or offenses for 2 
which the prisoner was under lawful arrest, in lawful custody or in 3 
lawful confinement when the prisoner violated the provisions of 4 
subsection 1. 5 
 6.  In addition to any other penalty, the court shall order a 6 
prisoner who violates any provision of paragraph (d) of subsection 1 7 
to reimburse the appropriate person or governmental body for the 8 
cost of any examinations or testing: 9 
 (a) Conducted pursuant to paragraphs (a) and (b) of subsection 10 
8; or 11 
 (b) Paid for pursuant to subparagraph (2) of paragraph (c) of 12 
subsection 8. 13 
 7.  The warden, sheriff, administrator or other person 14 
responsible for administering a prison shall immediately and fully 15 
investigate any act described in subsection 1 that is reported or 16 
suspected to have been committed in the prison. 17 
 8.  If there is probable cause to believe that an act described in 18 
paragraph (d) of subsection 1 has been committed in a prison: 19 
 (a) Each prisoner believed to have committed the act or to have 20 
been the bodily source of any portion of the excrement or bodily 21 
fluid involved in the act shall submit to any appropriate 22 
examinations and testing to determine whether each such prisoner 23 
has any communicable disease. 24 
 (b) If possible, a sample of the excrement or bodily fluid 25 
involved in the act must be recovered and tested to determine 26 
whether any communicable disease is present in the excrement or 27 
bodily fluid. 28 
 (c) If the excrement or bodily fluid involved in the act came into 29 
physical contact with any portion of the body of an officer or 30 
employee of a prison or law enforcement agency: 31 
  (1) The results of any examinations or testing conducted 32 
pursuant to paragraphs (a) and (b) must be provided to each such 33 
officer, employee or other person; and 34 
  (2) For each such officer or employee: 35 
   (I) Of a prison, the person or governmental body 36 
operating the prison where the act was committed shall pay for any 37 
appropriate examinations and testing requested by the officer or 38 
employee to determine whether a communicable disease was 39 
transmitted to the officer or employee as a result of the act; and 40 
   (II) Of any law enforcement agency, the law enforcement 41 
agency that employs the officer or employee shall pay for any 42 
appropriate examinations and testing requested by the officer or 43 
employee to determine whether a communicable disease was 44 
transmitted to the officer or employee as a result of the act. 45   
 	– 17 – 
 
 
- 	*SB439* 
 (d) The results of the investigation conducted pursuant to 1 
subsection 7 and the results of any examinations or testing 2 
conducted pursuant to paragraphs (a) and (b) must be submitted to 3 
the district attorney of the county in which the act was committed or 4 
to the Office of the Attorney General for possible prosecution of 5 
each prisoner who committed the act. 6 
 9.  If a prisoner is charged with committing an act described in 7 
paragraph (d) of subsection 1 and a victim or an intended victim of 8 
the act was an officer or employee of a prison or law enforcement 9 
agency, the prosecuting attorney shall not dismiss the charge in 10 
exchange for a plea of guilty, guilty but mentally ill or nolo 11 
contendere to a lesser charge or for any other reason unless the 12 
prosecuting attorney knows or it is obvious that the charge is not 13 
supported by probable cause or cannot be proved at the time of trial. 14 
 10.  The provisions of this section do not apply to a prisoner 15 
who is in residential confinement or to a prisoner who commits an 16 
act described in subsection 1 if the act: 17 
 (a) Is otherwise lawful and is authorized by the warden, sheriff, 18 
administrator or other person responsible for administering the 19 
prison, or his or her designee, and the prisoner performs the act in 20 
accordance with the directions or instructions given to the prisoner 21 
by that person; 22 
 (b) Involves the discharge of human excrement or bodily fluid 23 
directly from the body of the prisoner and the discharge is the direct 24 
result of a temporary or permanent injury, disease or medical 25 
condition afflicting the prisoner that prevents the prisoner from 26 
having physical control over the discharge of his or her own 27 
excrement or bodily fluid; or 28 
 (c) Constitutes voluntary sexual conduct with another person in 29 
violation of the provisions of NRS 212.187. 30 
 Sec. 14.  NRS 232.320 is hereby amended to read as follows: 31 
 232.320 1.  The Director: 32 
 (a) Shall appoint, with the consent of the Governor, 33 
administrators of the divisions of the Department, who are 34 
respectively designated as follows: 35 
  (1) The Administrator of the Aging and Disability Services 36 
Division; 37 
  (2) The Administrator of the Division of Welfare and 38 
Supportive Services; 39 
  (3) The Administrator of the Division of Child and Family 40 
Services; 41 
  (4) The Administrator of the Division of Health Care 42 
Financing and Policy; and 43 
  (5) The Administrator of the Division of Public and 44 
Behavioral Health. 45   
 	– 18 – 
 
 
- 	*SB439* 
 (b) Shall administer, through the divisions of the Department, 1 
the provisions of chapters 63, 424, 425, 427A, 432A to 442, 2 
inclusive, 446 to 450, inclusive, 458A and 656A of NRS, NRS 3 
127.220 to 127.310, inclusive, 422.001 to 422.410, inclusive, and 4 
sections 20, 21 and 22 of this act, 422.580, 432.010 to 432.133, 5 
inclusive, 432B.6201 to 432B.626, inclusive, 444.002 to 444.430, 6 
inclusive, and 445A.010 to 445A.055, inclusive, and all other 7 
provisions of law relating to the functions of the divisions of the 8 
Department, but is not responsible for the clinical activities of the 9 
Division of Public and Behavioral Health or the professional line 10 
activities of the other divisions. 11 
 (c) Shall administer any state program for persons with 12 
developmental disabilities established pursuant to the 13 
Developmental Disabilities Assistance and Bill of Rights Act of 14 
2000, 42 U.S.C. §§ 15001 et seq. 15 
 (d) Shall, after considering advice from agencies of local 16 
governments and nonprofit organizations which provide social 17 
services, adopt a master plan for the provision of human services in 18 
this State. The Director shall revise the plan biennially and deliver a 19 
copy of the plan to the Governor and the Legislature at the 20 
beginning of each regular session. The plan must: 21 
  (1) Identify and assess the plans and programs of the 22 
Department for the provision of human services, and any 23 
duplication of those services by federal, state and local agencies; 24 
  (2) Set forth priorities for the provision of those services; 25 
  (3) Provide for communication and the coordination of those 26 
services among nonprofit organizations, agencies of local 27 
government, the State and the Federal Government; 28 
  (4) Identify the sources of funding for services provided by 29 
the Department and the allocation of that funding; 30 
  (5) Set forth sufficient information to assist the Department 31 
in providing those services and in the planning and budgeting for the 32 
future provision of those services; and 33 
  (6) Contain any other information necessary for the 34 
Department to communicate effectively with the Federal 35 
Government concerning demographic trends, formulas for the 36 
distribution of federal money and any need for the modification of 37 
programs administered by the Department. 38 
 (e) May, by regulation, require nonprofit organizations and state 39 
and local governmental agencies to provide information regarding 40 
the programs of those organizations and agencies, excluding 41 
detailed information relating to their budgets and payrolls, which the 42 
Director deems necessary for the performance of the duties imposed 43 
upon him or her pursuant to this section. 44 
 (f) Has such other powers and duties as are provided by law. 45   
 	– 19 – 
 
 
- 	*SB439* 
 2.  Notwithstanding any other provision of law, the Director, or 1 
the Director’s designee, is responsible for appointing and removing 2 
subordinate officers and employees of the Department. 3 
 Sec. 15.  NRS 287.010 is hereby amended to read as follows: 4 
 287.010 1.  The governing body of any county, school 5 
district, municipal corporation, political subdivision, public 6 
corporation or other local governmental agency of the State of 7 
Nevada may: 8 
 (a) Adopt and carry into effect a system of group life, accident 9 
or health insurance, or any combination thereof, for the benefit of its 10 
officers and employees, and the dependents of officers and 11 
employees who elect to accept the insurance and who, where 12 
necessary, have authorized the governing body to make deductions 13 
from their compensation for the payment of premiums on the 14 
insurance. 15 
 (b) Purchase group policies of life, accident or health insurance, 16 
or any combination thereof, for the benefit of such officers and 17 
employees, and the dependents of such officers and employees, as 18 
have authorized the purchase, from insurance companies authorized 19 
to transact the business of such insurance in the State of Nevada, 20 
and, where necessary, deduct from the compensation of officers and 21 
employees the premiums upon insurance and pay the deductions 22 
upon the premiums. 23 
 (c) Provide group life, accident or health coverage through a 24 
self-insurance reserve fund and, where necessary, deduct 25 
contributions to the maintenance of the fund from the compensation 26 
of officers and employees and pay the deductions into the fund. The 27 
money accumulated for this purpose through deductions from the 28 
compensation of officers and employees and contributions of the 29 
governing body must be maintained as an internal service fund as 30 
defined by NRS 354.543. The money must be deposited in a state or 31 
national bank or credit union authorized to transact business in the 32 
State of Nevada. Any independent administrator of a fund created 33 
under this section is subject to the licensing requirements of chapter 34 
683A of NRS, and must be a resident of this State. Any contract 35 
with an independent administrator must be approved by the 36 
Commissioner of Insurance as to the reasonableness of 37 
administrative charges in relation to contributions collected and 38 
benefits provided. The provisions of NRS 686A.135, 687B.352, 39 
687B.408, 687B.723, 687B.725, 689B.030 to 689B.050, inclusive, 40 
and sections 42, 43 and 44 of this act, 689B.265, 689B.287 and 41 
689B.500 apply to coverage provided pursuant to this paragraph, 42 
except that the provisions of NRS 689B.0378, 689B.03785 and 43 
689B.500 only apply to coverage for active officers and employees 44   
 	– 20 – 
 
 
- 	*SB439* 
of the governing body, or the dependents of such officers and 1 
employees. 2 
 (d) Defray part or all of the cost of maintenance of a self-3 
insurance fund or of the premiums upon insurance. The money for 4 
contributions must be budgeted for in accordance with the laws 5 
governing the county, school district, municipal corporation, 6 
political subdivision, public corporation or other local governmental 7 
agency of the State of Nevada. 8 
 2.  If a school district offers group insurance to its officers and 9 
employees pursuant to this section, members of the board of trustees 10 
of the school district must not be excluded from participating in the 11 
group insurance. If the amount of the deductions from compensation 12 
required to pay for the group insurance exceeds the compensation to 13 
which a trustee is entitled, the difference must be paid by the trustee. 14 
 3.  In any county in which a legal services organization exists, 15 
the governing body of the county, or of any school district, 16 
municipal corporation, political subdivision, public corporation or 17 
other local governmental agency of the State of Nevada in the 18 
county, may enter into a contract with the legal services 19 
organization pursuant to which the officers and employees of the 20 
legal services organization, and the dependents of those officers and 21 
employees, are eligible for any life, accident or health insurance 22 
provided pursuant to this section to the officers and employees, and 23 
the dependents of the officers and employees, of the county, school 24 
district, municipal corporation, political subdivision, public 25 
corporation or other local governmental agency. 26 
 4.  If a contract is entered into pursuant to subsection 3, the 27 
officers and employees of the legal services organization: 28 
 (a) Shall be deemed, solely for the purposes of this section, to be 29 
officers and employees of the county, school district, municipal 30 
corporation, political subdivision, public corporation or other local 31 
governmental agency with which the legal services organization has 32 
contracted; and 33 
 (b) Must be required by the contract to pay the premiums or 34 
contributions for all insurance which they elect to accept or of which 35 
they authorize the purchase. 36 
 5.  A contract that is entered into pursuant to subsection 3: 37 
 (a) Must be submitted to the Commissioner of Insurance for 38 
approval not less than 30 days before the date on which the contract 39 
is to become effective. 40 
 (b) Does not become effective unless approved by the 41 
Commissioner. 42 
 (c) Shall be deemed to be approved if not disapproved by the 43 
Commissioner within 30 days after its submission. 44   
 	– 21 – 
 
 
- 	*SB439* 
 6.  As used in this section, “legal services organization” means 1 
an organization that operates a program for legal aid and receives 2 
money pursuant to NRS 19.031. 3 
 Sec. 16.  NRS 287.04335 is hereby amended to read as 4 
follows: 5 
 287.04335 If the Board provides health insurance through a 6 
plan of self-insurance, it shall comply with the provisions of NRS 7 
686A.135, 687B.352, 687B.409, 687B.723, 687B.725, 689B.0353, 8 
689B.255, 695C.1723, 695G.150, 695G.155, 695G.160, 695G.162, 9 
695G.1635, 695G.164, 695G.1645, 695G.1665, 695G.167, 10 
695G.1675, 695G.170 to 695G.174, inclusive, and sections 71 and 11 
72 of this act, 695G.176, 695G.177, 695G.200 to 695G.230, 12 
inclusive, 695G.241 to 695G.310, inclusive, and 695G.405 [,] and 13 
section 73 of this act in the same manner as an insurer that is 14 
licensed pursuant to title 57 of NRS is required to comply with those 15 
provisions. 16 
 Sec. 17.  NRS 389.036 is hereby amended to read as follows: 17 
 389.036 1.  The board of trustees of a school district shall 18 
[establish] : 19 
 (a) Establish a course or unit of a course of [: 20 
 (a) Factual] evidence-based, factual instruction [concerning the 21 
human immunodeficiency virus; and 22 
 (b) Instruction on the human reproductive system, related 23 
communicable diseases and sexual responsibility. 24 
 2.] in sexuality education. The course of instruction must 25 
comply with the standards of content and performance for a 26 
course of study in health established by the Council to Establish 27 
Academic Standards for Public Schools pursuant to NRS 389.520 28 
and must be appropriate for the ages of the pupils who receive the 29 
instruction. The course must include, without limitation, 30 
instruction concerning: 31 
  (1) Reproductive and sexual anatomy and physiology, 32 
including, without limitation, biological, psychosocial and 33 
emotional changes that accompany maturation; 34 
  (2) Puberty, pregnancy, parenting, body image and gender 35 
stereotypes; 36 
  (3) The human immunodeficiency virus and other sexually 37 
transmitted infections and related communicable diseases; 38 
  (4) The benefits, potential side effects and proper use of 39 
methods approved by the United States Food and Drug 40 
Administration for preventing pregnancy and sexually transmitted 41 
infections; 42 
  (5) The ways in which the use of alcohol and drugs affect 43 
responsible decision making;  44   
 	– 22 – 
 
 
- 	*SB439* 
  (6) The impact of media and peers on the thoughts, feelings 1 
and behaviors of pupils related to sexuality;  2 
  (7) How to identify, prevent and respond to domestic 3 
violence, sexual abuse and sexual assault, including, without 4 
limitation, medical and legal resources and counseling for 5 
survivors of such crimes; 6 
  (8) Statutes related to age of consent and statutory rape, 7 
including, without limitation, NRS 200.366, 200.727, 201.230, 8 
201.540 and 201.550, and preventing statutory rape;  9 
  (9) Statutes related to the transmission and possession of 10 
sexually explicit images, including, without limitation, NRS 11 
200.604, 200.727, 200.730 and 200.780, and avoiding participation 12 
in such acts and exploitation of others through the creation and 13 
transmission of such images over the Internet or in any other 14 
manner; and 15 
  (10) The manner in which to locate and access reproductive 16 
health services, including, without limitation, obtaining 17 
contraceptives, barrier methods, cancer screenings and testing for 18 
and the treatment of sexually transmitted infections; and 19 
 (b) Periodically revise the content of the course or unit of a 20 
course of instruction established pursuant to paragraph (a) as 21 
necessary to ensure that the content is current, appropriate for the 22 
ages of the pupils and, as applicable, medically accurate. 23 
 2.  The course or unit of a course established pursuant to 24 
subsection 1 must: 25 
 (a) Use instructional methods and materials that promote the 26 
inclusion and acceptance of pupils regardless of race, gender, 27 
gender identity or expression, religion, sexual orientation, ethnic 28 
or cultural background or disability; 29 
 (b) Promote the development of skills, including, without 30 
limitation, setting goals that are needed to make responsible 31 
decisions about sexuality and sexual behavior throughout life; 32 
 (c) Be designed to provide equally meaningful instruction to 33 
pupils regardless of their level of sexual experience or whether 34 
they are currently engaging in sexual activity; 35 
 (d) Emphasize that abstaining from sexual activity is the only 36 
way to ensure the avoidance of pregnancy and sexually 37 
transmitted infections;  38 
 (e) Emphasize the use of interpersonal skills to develop healthy 39 
relationships, including, without limitation, friendships, marriage 40 
and romantic and familial relationships; and 41 
 (f) Involve the parents or guardians of pupils in the instruction 42 
provided and encourage pupils to communicate with their families 43 
concerning issues relating to sexuality. 44   
 	– 23 – 
 
 
- 	*SB439* 
 3. Each board of trustees shall appoint an advisory committee 1 
consisting of: 2 
 (a) Five parents of children who attend schools in the district; 3 
and 4 
 (b) Four representatives, one from each of four of the following 5 
professions or occupations: 6 
  (1) Medicine or nursing; 7 
  (2) Counseling; 8 
  (3) Religion; 9 
  (4) Pupils who attend schools in the district; or 10 
  (5) Teaching. 11 
[ This]  12 
 4. The advisory committee appointed pursuant to subsection 3 13 
shall advise the district concerning the content of and materials to be 14 
used in a course or unit of a course of instruction established 15 
pursuant to this section, and the recommended ages of the pupils to 16 
whom the course or unit is offered. The final decision on these 17 
matters must be that of the board of trustees. 18 
 [3.] 5.  The subjects of the [courses] course or unit of a course 19 
of instruction may be taught only by a teacher , [or] school nurse 20 
[whose qualifications have] , provider of health care or other 21 
person who has been [previously] approved by the board of 22 
trustees. The board of trustees may approve a person for the 23 
purposes of this subsection if it determines that the person has 24 
demonstrated competency in the applicable subject and the use of 25 
the required instructional materials. 26 
 [4.] 6.  The parent or guardian of each pupil to whom a course 27 
or unit of a course of instruction established pursuant to this 28 
section is offered must first be furnished written notice that the 29 
course or unit of a course will be offered. The notice must be given 30 
in the usual manner used by the local district to transmit written 31 
material to parents, and must contain a form for the signature of the 32 
parent or guardian of the pupil consenting to the pupil’s attendance. 33 
Upon receipt of the written consent of the parent or guardian, the 34 
pupil may attend the course [.] or unit of a course. If the written 35 
consent of the parent or guardian is not received, the pupil must be 36 
excused from such attendance without any penalty as to credits or 37 
academic standing. Any course or unit of a course offered pursuant 38 
to this section is not a requirement for graduation. 39 
 [5.] 7.  All instructional materials to be used in a course or unit 40 
of a course of instruction established pursuant to this section must 41 
be available for inspection by parents or guardians of pupils at 42 
reasonable times and locations before the course is taught, and 43 
appropriate written notice of the availability of the material must be 44 
furnished to all parents and guardians. 45   
 	– 24 – 
 
 
- 	*SB439* 
 8. As used in this section, “provider of health care” has the 1 
meaning ascribed to it in NRS 629.031. 2 
 Sec. 18.  NRS 389.520 is hereby amended to read as follows: 3 
 389.520 1.  The Council shall: 4 
 (a) Establish standards of content and performance, including, 5 
without limitation, a prescription of the resulting level of 6 
achievement, for the grade levels set forth in subsection 5, based 7 
upon the content of each course, that is expected of pupils for the 8 
following courses of study: 9 
  (1) English language arts; 10 
  (2) Mathematics; 11 
  (3) Science; 12 
  (4) Social studies, which includes only the subjects of 13 
history, geography, economics, civics, financial literacy and 14 
multicultural education; 15 
  (5) The arts; 16 
  (6) Computer education and technology, which includes 17 
computer science and computational thinking; 18 
  (7) Health; 19 
  (8) Physical education; and  20 
  (9) A foreign or world language. 21 
 (b) Establish a schedule for the periodic review and, if 22 
necessary, revision of the standards of content and performance. The 23 
review must include, without limitation, the review required 24 
pursuant to NRS 390.115 of the results of pupils on the 25 
examinations administered pursuant to NRS 390.105. 26 
 (c) Assign priorities to the standards of content and performance 27 
relative to importance and degree of emphasis and revise the 28 
standards, if necessary, based upon the priorities. 29 
 2.  The standards for computer education and technology must 30 
include a policy for the ethical, safe and secure use of computers 31 
and other electronic devices. The policy must include, without 32 
limitation: 33 
 (a) The ethical use of computers and other electronic devices, 34 
including, without limitation: 35 
  (1) Rules of conduct for the acceptable use of the Internet 36 
and other electronic devices; and 37 
  (2) Methods to ensure the prevention of: 38 
   (I) Cyber-bullying; 39 
   (II) Plagiarism; and 40 
   (III) The theft of information or data in an electronic 41 
form; 42 
 (b) The safe use of computers and other electronic devices, 43 
including, without limitation, methods to: 44   
 	– 25 – 
 
 
- 	*SB439* 
  (1) Avoid cyber-bullying and other unwanted electronic 1 
communication, including, without limitation, communication with 2 
on-line predators; 3 
  (2) Recognize when an on-line electronic communication is 4 
dangerous or potentially dangerous; and 5 
  (3) Report a dangerous or potentially dangerous on-line 6 
electronic communication to the appropriate school personnel; 7 
 (c) The secure use of computers and other electronic devices, 8 
including, without limitation: 9 
  (1) Methods to maintain the security of personal identifying 10 
information and financial information, including, without limitation, 11 
identifying unsolicited electronic communication which is sent for 12 
the purpose of obtaining such personal and financial information for 13 
an unlawful purpose; 14 
  (2) The necessity for secure passwords or other unique 15 
identifiers; 16 
  (3) The effects of a computer contaminant; 17 
  (4) Methods to identify unsolicited commercial material; and 18 
  (5) The dangers associated with social networking Internet 19 
sites; and 20 
 (d) A designation of the level of detail of instruction as 21 
appropriate for the grade level of pupils who receive the instruction. 22 
 3.  The standards for social studies must include multicultural 23 
education, including, without limitation, information relating to 24 
contributions made by men and women from various racial and 25 
ethnic backgrounds. The Council shall consult with members of the 26 
community who represent the racial and ethnic diversity of this 27 
State in developing such standards. 28 
 4. The standards for health must include [mental] : 29 
 (a) Mental health and the relationship between mental health 30 
and physical health. 31 
 (b) Standards for sexuality education. The standards for other 32 
courses may include topics relating to sexuality education where 33 
appropriate. 34 
 5.  The Council shall establish standards of content and 35 
performance for each grade level in kindergarten and grades 1 to 8, 36 
inclusive, for English language arts and mathematics. The Council 37 
shall establish standards of content and performance for the grade 38 
levels selected by the Council for the other courses of study 39 
prescribed in subsection 1. 40 
 6.  The Council shall forward to the State Board the standards 41 
of content and performance established by the Council for each 42 
course of study. The State Board shall: 43 
 (a) Adopt the standards for each course of study, as submitted 44 
by the Council; or 45   
 	– 26 – 
 
 
- 	*SB439* 
 (b) If the State Board objects to the standards for a course of 1 
study or a particular grade level for a course of study, return those 2 
standards to the Council with a written explanation setting forth the 3 
reason for the objection. 4 
 7.  If the State Board returns to the Council the standards of 5 
content and performance for a course of study or a grade level, the 6 
Council shall: 7 
 (a) Consider the objection provided by the State Board and 8 
determine whether to revise the standards based upon the objection; 9 
and 10 
 (b) Return the standards or the revised standards, as applicable, 11 
to the State Board. 12 
 The State Board shall adopt the standards of content and 13 
performance or the revised standards, as applicable. 14 
 8.  The Council shall work in cooperation with the State Board 15 
to prescribe the examinations required by NRS 390.105. 16 
 9.  As used in this section: 17 
 (a) “Computer contaminant” has the meaning ascribed to it in 18 
NRS 205.4737. 19 
 (b) “Cyber-bullying” has the meaning ascribed to it in  20 
NRS 388.123. 21 
 (c) “Electronic communication” has the meaning ascribed to it 22 
in NRS 388.124. 23 
 Sec. 19.  Chapter 422 of NRS is hereby amended by adding 24 
thereto the provisions set forth as sections 20 and 21 of this act. 25 
 Sec. 20.  1. The Director shall include in the State Plan for 26 
Medicaid a requirement that the State pay the nonfederal share of 27 
expenses for any service for the treatment of substance use 28 
disorder provided by a provider of primary care if the service is 29 
included in the State Plan when provided by a specialist and: 30 
 (a) The service is within the scope of practice of the provider of 31 
primary care; or  32 
 (b) The provider of primary care is capable of providing the 33 
service safely and effectively in consultation with a specialist and 34 
the provider engages in such consultation. 35 
 2. As used in this section, “primary care” means the practice 36 
of family medicine, pediatrics, internal medicine, obstetrics and 37 
gynecology and midwifery.  38 
 Sec. 21.  When calculating the amount of the contribution by 39 
a recipient of Medicaid towards a deductible, copayment, 40 
coinsurance or any other cost-sharing requirement for 41 
prescription drugs, the Department or any pharmacy benefit 42 
manager or health maintenance organization that manages 43 
pharmacy benefits for the Department pursuant to NRS 422.4053 44   
 	– 27 – 
 
 
- 	*SB439* 
must include the amount paid by the recipient or another person 1 
or entity on behalf of the recipient for a prescription drug: 2 
 1. That has no generic equivalent;  3 
 2. For which the Department, pharmacy benefit manager or 4 
health maintenance organization has imposed a requirement for 5 
prior authorization or a step therapy protocol pursuant to  6 
NRS 422.403;  7 
 3. Which is only covered under the State Plan for Medicaid 8 
after the recipient: 9 
 (a) Obtains an exception to a general policy of the 10 
Department, pharmacy benefit manager or health maintenance 11 
organization; or  12 
 (b) Wins an appeal of such a policy; or 13 
 4.  That is prescribed to: 14 
 (a) Prevent the acquisition of human immunodeficiency virus; 15 
 (b) Treat human immunodeficiency virus or hepatitis C; 16 
 (c) Provide medication-assisted treatment for opioid use 17 
disorder; or 18 
 (d) Support safe withdrawal from substance use disorder. 19 
 Sec. 22.  NRS 422.27173 is hereby amended to read as 20 
follows: 21 
 422.27173 The Director shall include in the State Plan for 22 
Medicaid a requirement that the State must pay the nonfederal share 23 
of expenditures incurred for : 24 
 1. Testing for and the treatment and prevention of sexually 25 
transmitted diseases, including, without limitation, Chlamydia 26 
trachomatis, gonorrhea, syphilis, human immunodeficiency virus 27 
and hepatitis B and C, for all recipients of Medicaid, regardless of 28 
age. Services covered pursuant to this section must include, 29 
without limitation, the examination of a pregnant woman for the 30 
discovery of: 31 
 [1.] (a) Chlamydia trachomatis, gonorrhea, hepatitis B and 32 
hepatitis C in accordance with NRS 442.013. 33 
 [2.] (b) Syphilis in accordance with NRS 442.010. 34 
 2. Condoms for recipients of Medicaid who are 13 years of 35 
age or older. 36 
 Sec. 23.  NRS 422.27235 is hereby amended to read as 37 
follows: 38 
 422.27235 1. The Director shall include in the State Plan for 39 
Medicaid a requirement that the State pay the nonfederal share of 40 
expenditures incurred for:  41 
 [1.] (a) Any laboratory testing that is necessary for therapy that 42 
uses a drug approved by the United States Food and Drug 43 
Administration for preventing the acquisition of human 44 
immunodeficiency virus . [; and]  45   
 	– 28 – 
 
 
- 	*SB439* 
 [2.] (b) The services of a pharmacist described in NRS 1 
639.28085. The State must provide reimbursement for such services 2 
at a rate equal to the rate of reimbursement provided to a physician, 3 
physician assistant or advanced practice registered nurse for similar 4 
services.  5 
 (c) Any service to test for, prevent or treat human 6 
immunodeficiency virus or hepatitis C provided by a provider of 7 
primary care if the service is covered when provided by a specialist 8 
and: 9 
  (1) The service is within the scope of practice of the 10 
provider of primary care; or  11 
  (2) The provider of primary care is capable of providing the 12 
service safely and effectively in consultation with a specialist and 13 
the provider engages in such consultation. 14 
 2. The Director shall include in the State Plan for Medicaid a 15 
requirement that the State reimburse an advanced practice 16 
registered nurse or a physician assistant for any service to test for, 17 
prevent or treat human immunodeficiency virus or hepatitis C at a 18 
rate equal to the rate of reimbursement provided to a physician for 19 
similar services. 20 
 3. As used in this section, “primary care” means the practice 21 
of family medicine, pediatrics, internal medicine, obstetrics and 22 
gynecology and midwifery.  23 
 Sec. 24.  NRS 422.401 is hereby amended to read as follows: 24 
 422.401 As used in NRS 422.401 to 422.406, inclusive, and 25 
section 21 of this act, unless the context otherwise requires, the 26 
words and terms defined in NRS 422.4015 to 422.4024, inclusive, 27 
and section 21 of this act have the meanings ascribed to them in 28 
those sections. 29 
 Sec. 25.  NRS 422.4025 is hereby amended to read as follows: 30 
 422.4025 1.  The Department shall: 31 
 (a) By regulation, develop a list of preferred prescription drugs 32 
to be used for the Medicaid program and the Children’s Health 33 
Insurance Program, and each public or nonprofit health benefit plan 34 
that elects to use the list of preferred prescription drugs as its 35 
formulary pursuant to NRS 287.012, 287.0433 or 687B.407; and 36 
 (b) Negotiate and enter into agreements to purchase the drugs 37 
included on the list of preferred prescription drugs on behalf of the 38 
health benefit plans described in paragraph (a) or enter into a 39 
contract pursuant to NRS 422.4053 with a pharmacy benefit 40 
manager, health maintenance organization or one or more public or 41 
private entities in this State, the District of Columbia or other states 42 
or territories of the United States, as appropriate, to negotiate such 43 
agreements. 44   
 	– 29 – 
 
 
- 	*SB439* 
 2.  The Department shall, by regulation, establish a list of 1 
prescription drugs which must be excluded from any restrictions that 2 
are imposed by the Medicaid program on drugs that are on the list of 3 
preferred prescription drugs established pursuant to subsection 1. 4 
The list established pursuant to this subsection must include, 5 
without limitation: 6 
 (a) Prescription drugs that are prescribed for the treatment of the 7 
human immunodeficiency virus, including, without limitation, 8 
antiretroviral medications; 9 
 (b) Antirejection medications for organ transplants; 10 
 (c) Antihemophilic medications; [and] 11 
 (d) Any prescription drug described in paragraph (b) of 12 
subsection 4; and 13 
 (e) Any prescription drug which the Board identifies as 14 
appropriate for exclusion from any restrictions that are imposed by 15 
the Medicaid program on drugs that are on the list of preferred 16 
prescription drugs. 17 
 3.  The regulations must provide that the Board makes the final 18 
determination of: 19 
 (a) Whether a class of therapeutic prescription drugs is included 20 
on the list of preferred prescription drugs and is excluded from any 21 
restrictions that are imposed by the Medicaid program on drugs that 22 
are on the list of preferred prescription drugs; 23 
 (b) Which therapeutically equivalent prescription drugs will be 24 
reviewed for inclusion on the list of preferred prescription drugs and 25 
for exclusion from any restrictions that are imposed by the Medicaid 26 
program on drugs that are on the list of preferred prescription drugs; 27 
and 28 
 (c) Which prescription drugs should be excluded from any 29 
restrictions that are imposed by the Medicaid program on drugs that 30 
are on the list of preferred prescription drugs based on continuity of 31 
care concerning a specific diagnosis, condition, class of therapeutic 32 
prescription drugs or medical specialty. 33 
 4.  The list of preferred prescription drugs established pursuant 34 
to subsection 1 must include, without limitation: 35 
 (a) Any prescription drug determined by the Board to be 36 
essential for treating sickle cell disease and its variants; and 37 
 (b) [Prescription] All prescription drugs approved by the United 38 
States Food and Drug Administration to [prevent] : 39 
  (1) Prevent the acquisition of human immunodeficiency 40 
virus [.] or hepatitis C or treat those diseases. 41 
  (2) Provide medication-assisted treatment for opioid use 42 
disorder, including, without limitation, buprenorphine, methadone 43 
and naltrexone. 44   
 	– 30 – 
 
 
- 	*SB439* 
  (3) Support safe withdrawal from substance use disorder, 1 
including, without limitation, lofexidine. 2 
 5. The regulations must provide that each new pharmaceutical 3 
product and each existing pharmaceutical product for which there is 4 
new clinical evidence supporting its inclusion on the list of preferred 5 
prescription drugs must be made available pursuant to the Medicaid 6 
program with prior authorization until the Board reviews the product 7 
or the evidence. 8 
 6. On or before February 1 of each year, the Department shall: 9 
 (a) Compile a report concerning the agreements negotiated 10 
pursuant to paragraph (b) of subsection 1 and contracts entered into 11 
pursuant to NRS 422.4053 which must include, without limitation, 12 
the financial effects of obtaining prescription drugs through those 13 
agreements and contracts, in total and aggregated separately for 14 
agreements negotiated by the Department, contracts with a 15 
pharmacy benefit manager, contracts with a health maintenance 16 
organization and contracts with public and private entities from this 17 
State, the District of Columbia and other states and territories of the 18 
United States; and 19 
 (b) Post the report on an Internet website maintained by the 20 
Department and submit the report to the Director of the Legislative 21 
Counsel Bureau for transmittal to: 22 
  (1) In odd-numbered years, the Legislature; or 23 
  (2) In even-numbered years, the Legislative Commission. 24 
 Sec. 26.  NRS 608.156 is hereby amended to read as follows: 25 
 608.156 1.  [If] In addition to any benefits required by NRS 26 
608.1555, an employer provides health benefits for his or her 27 
employees, the employer shall provide benefits for the expenses for 28 
the treatment of alcohol and substance use disorders. The annual 29 
benefits provided by the employer must [consist of:] include, 30 
without limitation: 31 
 (a) Treatment for withdrawal from the physiological effects of 32 
alcohol or drugs, with a maximum benefit of $1,500 per calendar 33 
year. 34 
 (b) Treatment for a patient admitted to a facility, with a 35 
maximum benefit of $9,000 per calendar year. 36 
 (c) Counseling for a person, group or family who is not admitted 37 
to a facility, with a maximum benefit of $2,500 per calendar year. 38 
 2.  The maximum amount which may be paid in the lifetime of 39 
the insured for any combination of the treatments listed in 40 
subsection 1 is $39,000. 41 
 3.  Except as otherwise provided in NRS 687B.409, these 42 
benefits must be paid in the same manner as benefits for any other 43 
illness covered by the employer are paid. 44   
 	– 31 – 
 
 
- 	*SB439* 
 4.  The employee is entitled to these benefits if treatment is 1 
received in any: 2 
 (a) Program for the treatment of alcohol or substance use 3 
disorders which is certified by the Division of Public and Behavioral 4 
Health of the Department of Health and Human Services. 5 
 (b) Hospital or other medical facility or facility for the 6 
dependent which is licensed by the Division of Public and 7 
Behavioral Health of the Department of Health and Human 8 
Services, is accredited by The Joint Commission or CARF 9 
International and provides a program for the treatment of alcohol or 10 
substance use disorders as part of its accredited activities. 11 
 Sec. 27.  NRS 629.093 is hereby amended to read as follows: 12 
 629.093 Unless a specific statute or regulation requires or 13 
authorizes a greater number of hours, a provider of health care may 14 
use credit earned for continuing education relating to Alzheimer’s 15 
disease or the stigma, discrimination and unrecognized bias 16 
toward persons who have acquired or are at a high risk of 17 
acquiring human immunodeficiency virus in place of not more 18 
than 2 hours each year of the continuing education that the provider 19 
of health care is required to complete, other than any continuing 20 
education relating to ethics that the provider of health care is 21 
required to complete. 22 
 Sec. 28.  NRS 630.253 is hereby amended to read as follows: 23 
 630.253 1.  The Board shall, as a prerequisite for the: 24 
 (a) Renewal of a license as a physician assistant; or 25 
 (b) Biennial registration of the holder of a license to practice 26 
medicine, 27 
 require each holder to submit evidence of compliance with the 28 
requirements for continuing education as set forth in regulations 29 
adopted by the Board. 30 
 2.  These requirements: 31 
 (a) May provide for the completion of one or more courses of 32 
instruction relating to risk management in the performance of 33 
medical services. 34 
 (b) Must provide for the completion of a course of instruction, 35 
within 2 years after initial licensure, relating to the medical 36 
consequences of an act of terrorism that involves the use of a 37 
weapon of mass destruction. The course must provide at least 4 38 
hours of instruction that includes instruction in the following 39 
subjects: 40 
  (1) An overview of acts of terrorism and weapons of mass 41 
destruction; 42 
  (2) Personal protective equipment required for acts of 43 
terrorism; 44   
 	– 32 – 
 
 
- 	*SB439* 
  (3) Common symptoms and methods of treatment associated 1 
with exposure to, or injuries caused by, chemical, biological, 2 
radioactive and nuclear agents; 3 
  (4) Syndromic surveillance and reporting procedures for acts 4 
of terrorism that involve biological agents; and 5 
  (5) An overview of the information available on, and the use 6 
of, the Health Alert Network. 7 
 (c) Must provide for the completion by a holder of a license to 8 
practice medicine of a course of instruction within 2 years after 9 
initial licensure that provides at least 2 hours of instruction on 10 
evidence-based suicide prevention and awareness as described in 11 
subsection 6. 12 
 (d) Must provide for the completion of at least 2 hours of 13 
training in the screening, brief intervention and referral to treatment 14 
approach to substance use disorder within 2 years after initial 15 
licensure. 16 
 (e) Must provide for the biennial completion by each 17 
psychiatrist and each physician assistant practicing under the 18 
supervision of a psychiatrist of one or more courses of instruction 19 
that provide at least 2 hours of instruction relating to cultural 20 
competency and diversity, equity and inclusion. Such instruction:  21 
  (1) May include the training provided pursuant to NRS 22 
449.103, where applicable.  23 
  (2) Must be based upon a range of research from diverse 24 
sources. 25 
  (3) Must address persons of different cultural backgrounds, 26 
including, without limitation:  27 
   (I) Persons from various gender, racial and ethnic 28 
backgrounds;  29 
   (II) Persons from various religious backgrounds;  30 
   (III) Lesbian, gay, bisexual, transgender and questioning 31 
persons;  32 
   (IV) Children and senior citizens;  33 
   (V) Veterans;  34 
   (VI) Persons with a mental illness;  35 
   (VII) Persons with an intellectual disability, 36 
developmental disability or physical disability; and  37 
   (VIII) Persons who are part of any other population that a 38 
psychiatrist or a physician assistant practicing under the supervision 39 
of a psychiatrist may need to better understand, as determined by the 40 
Board. 41 
 (f) Must allow the holder of a license to receive credit toward 42 
the total amount of continuing education required by the Board for 43 
the completion of a course of instruction relating to genetic 44 
counseling and genetic testing. 45   
 	– 33 – 
 
 
- 	*SB439* 
 (g) Must provide for the completion by a physician or 1 
physician assistant who provides or supervises the provision of 2 
emergency medical services in a hospital or primary care of at 3 
least 2 hours of training in the stigma, discrimination and 4 
unrecognized bias toward persons who have acquired or are at a 5 
high risk of acquiring human immunodeficiency virus within 2 6 
years after beginning to provide or supervise the provision of such 7 
services or care. 8 
 3. The Board may determine whether to include in a program 9 
of continuing education courses of instruction relating to the 10 
medical consequences of an act of terrorism that involves the use of 11 
a weapon of mass destruction in addition to the course of instruction 12 
required by paragraph (b) of subsection 2. 13 
 4.  The Board shall encourage each holder of a license who 14 
treats or cares for persons who are more than 60 years of age to 15 
receive, as a portion of their continuing education, education in 16 
geriatrics and gerontology, including such topics as: 17 
 (a) The skills and knowledge that the licensee needs to address 18 
aging issues; 19 
 (b) Approaches to providing health care to older persons, 20 
including both didactic and clinical approaches; 21 
 (c) The biological, behavioral, social and emotional aspects of 22 
the aging process; and 23 
 (d) The importance of maintenance of function and 24 
independence for older persons. 25 
 5.  The Board shall encourage each holder of a license to 26 
practice medicine to receive, as a portion of his or her continuing 27 
education, training concerning methods for educating patients about 28 
how to effectively manage medications, including, without 29 
limitation, the ability of the patient to request to have the symptom 30 
or purpose for which a drug is prescribed included on the label 31 
attached to the container of the drug. 32 
 6.  The Board shall require each holder of a license to practice 33 
medicine to receive as a portion of his or her continuing education at 34 
least 2 hours of instruction every 4 years on evidence-based suicide 35 
prevention and awareness, which may include, without limitation, 36 
instruction concerning: 37 
 (a) The skills and knowledge that the licensee needs to detect 38 
behaviors that may lead to suicide, including, without limitation, 39 
post-traumatic stress disorder; 40 
 (b) Approaches to engaging other professionals in suicide 41 
intervention; and 42 
 (c) The detection of suicidal thoughts and ideations and the 43 
prevention of suicide. 44   
 	– 34 – 
 
 
- 	*SB439* 
 7.  The Board shall encourage each holder of a license to 1 
practice medicine or as a physician assistant to receive, as a portion 2 
of his or her continuing education, training and education in the 3 
diagnosis of rare diseases, including, without limitation: 4 
 (a) Recognizing the symptoms of pediatric cancer; and 5 
 (b) Interpreting family history to determine whether such 6 
symptoms indicate a normal childhood illness or a condition that 7 
requires additional examination. 8 
 8.  A holder of a license to practice medicine may not substitute 9 
the continuing education credits relating to suicide prevention and 10 
awareness required by this section for the purposes of satisfying an 11 
equivalent requirement for continuing education in ethics. 12 
 9.  Except as otherwise provided in NRS 630.2535, a holder of 13 
a license to practice medicine may substitute not more than 2 hours 14 
of continuing education credits in pain management, care for 15 
persons with an addictive disorder or the screening, brief 16 
intervention and referral to treatment approach to substance use 17 
disorder for the purposes of satisfying an equivalent requirement for 18 
continuing education in ethics. 19 
 10. As used in this section: 20 
 (a) “Act of terrorism” has the meaning ascribed to it in  21 
NRS 202.4415. 22 
 (b) “Biological agent” has the meaning ascribed to it in  23 
NRS 202.442. 24 
 (c) “Chemical agent” has the meaning ascribed to it in  25 
NRS 202.4425. 26 
 (d) “Primary care” means the practice of family medicine, 27 
pediatrics, internal medicine, obstetrics and gynecology and 28 
midwifery.  29 
 (e) “Radioactive agent” has the meaning ascribed to it in  30 
NRS 202.4437. 31 
 [(e)] (f) “Weapon of mass destruction” has the meaning 32 
ascribed to it in NRS 202.4445. 33 
 Sec. 29.  NRS 632.343 is hereby amended to read as follows: 34 
 632.343 1.  The Board shall not renew any license issued 35 
under this chapter until the licensee has submitted proof satisfactory 36 
to the Board of completion, during the 2-year period before renewal 37 
of the license, of 30 hours in a program of continuing education 38 
approved by the Board in accordance with regulations adopted by 39 
the Board. Except as otherwise provided in subsection 3, the 40 
licensee is exempt from this provision for the first biennial period 41 
after graduation from: 42 
 (a) An accredited school of professional nursing; 43 
 (b) An accredited school of practical nursing; 44   
 	– 35 – 
 
 
- 	*SB439* 
 (c) An approved school of professional nursing in the process of 1 
obtaining accreditation; or 2 
 (d) An approved school of practical nursing in the process of 3 
obtaining accreditation. 4 
 2.  The Board shall review all courses offered to nurses for the 5 
completion of the requirement set forth in subsection 1. The Board 6 
may approve nursing and other courses which are directly related to 7 
the practice of nursing as well as others which bear a reasonable 8 
relationship to current developments in the field of nursing or any 9 
special area of practice in which a licensee engages. These may 10 
include academic studies, workshops, extension studies, home study 11 
and other courses. 12 
 3.  The program of continuing education required by subsection 13 
1 must include: 14 
 (a) For a person licensed as an advanced practice registered 15 
nurse: 16 
  (1) A course of instruction to be completed within 2 years 17 
after initial licensure that provides at least 2 hours of instruction on 18 
suicide prevention and awareness as described in subsection 6. 19 
  (2) The ability to receive credit toward the total amount of 20 
continuing education required by subsection 1 for the completion of 21 
a course of instruction relating to genetic counseling and genetic 22 
testing. 23 
 (b) For each person licensed pursuant to this chapter, a course of 24 
instruction, to be completed within 2 years after initial licensure, 25 
relating to the medical consequences of an act of terrorism that 26 
involves the use of a weapon of mass destruction. The course must 27 
provide at least 4 hours of instruction that includes instruction in the 28 
following subjects: 29 
  (1) An overview of acts of terrorism and weapons of mass 30 
destruction; 31 
  (2) Personal protective equipment required for acts of 32 
terrorism; 33 
  (3) Common symptoms and methods of treatment associated 34 
with exposure to, or injuries caused by, chemical, biological, 35 
radioactive and nuclear agents; 36 
  (4) Syndromic surveillance and reporting procedures for acts 37 
of terrorism that involve biological agents; and 38 
  (5) An overview of the information available on, and the use 39 
of, the Health Alert Network. 40 
 (c) For each person licensed pursuant to this chapter, one or 41 
more courses of instruction that provide at least 2 hours of 42 
instruction relating to cultural competency and diversity, equity and 43 
inclusion to be completed biennially. Such instruction:  44   
 	– 36 – 
 
 
- 	*SB439* 
  (1) May include the training provided pursuant to NRS 1 
449.103, where applicable.  2 
  (2) Must be based upon a range of research from diverse 3 
sources. 4 
  (3) Must address persons of different cultural backgrounds, 5 
including, without limitation:  6 
   (I) Persons from various gender, racial and ethnic 7 
backgrounds;  8 
   (II) Persons from various religious backgrounds;  9 
   (III) Lesbian, gay, bisexual, transgender and questioning 10 
persons;  11 
   (IV) Children and senior citizens;  12 
   (V) Veterans;  13 
   (VI) Persons with a mental illness;  14 
   (VII) Persons with an intellectual disability, 15 
developmental disability or physical disability; and  16 
   (VIII) Persons who are part of any other population that a 17 
person licensed pursuant to this chapter may need to better 18 
understand, as determined by the Board. 19 
 (d) For a person licensed as an advanced practice registered 20 
nurse, at least 2 hours of training in the screening, brief intervention 21 
and referral to treatment approach to substance use disorder to be 22 
completed within 2 years after initial licensure. 23 
 (e) For each person licensed pursuant to this chapter who 24 
provides or supervises the provision of emergency medical services 25 
in a hospital or primary care, at least 2 hours of training in the 26 
stigma, discrimination and unrecognized bias toward persons who 27 
have acquired or are at a high risk of acquiring human 28 
immunodeficiency virus to be completed within 2 years after 29 
beginning to provide or supervise the provision of such services or 30 
care. 31 
 4.  The Board may determine whether to include in a program 32 
of continuing education courses of instruction relating to the 33 
medical consequences of an act of terrorism that involves the use of 34 
a weapon of mass destruction in addition to the course of instruction 35 
required by paragraph (b) of subsection 3. 36 
 5.  The Board shall encourage each licensee who treats or cares 37 
for persons who are more than 60 years of age to receive, as a 38 
portion of their continuing education, education in geriatrics and 39 
gerontology, including such topics as: 40 
 (a) The skills and knowledge that the licensee needs to address 41 
aging issues; 42 
 (b) Approaches to providing health care to older persons, 43 
including both didactic and clinical approaches; 44   
 	– 37 – 
 
 
- 	*SB439* 
 (c) The biological, behavioral, social and emotional aspects of 1 
the aging process; and 2 
 (d) The importance of maintenance of function and 3 
independence for older persons. 4 
 6.  The Board shall require each person licensed as an advanced 5 
practice registered nurse to receive as a portion of his or her 6 
continuing education at least 2 hours of instruction every 4 years on 7 
evidence-based suicide prevention and awareness or another course 8 
of instruction on suicide prevention and awareness that is approved 9 
by the Board which the Board has determined to be effective and 10 
appropriate. 11 
 7.  The Board shall encourage each person licensed as an 12 
advanced practice registered nurse to receive, as a portion of his or 13 
her continuing education, training and education in the diagnosis of 14 
rare diseases, including, without limitation: 15 
 (a) Recognizing the symptoms of pediatric cancer; and  16 
 (b) Interpreting family history to determine whether such 17 
symptoms indicate a normal childhood illness or a condition that 18 
requires additional examination. 19 
 8. As used in this section: 20 
 (a) “Act of terrorism” has the meaning ascribed to it in  21 
NRS 202.4415. 22 
 (b) “Biological agent” has the meaning ascribed to it in  23 
NRS 202.442. 24 
 (c) “Chemical agent” has the meaning ascribed to it in  25 
NRS 202.4425. 26 
 (d) “Primary care” means the practice of family medicine, 27 
pediatrics, internal medicine, obstetrics and gynecology and 28 
midwifery.  29 
 (e) “Radioactive agent” has the meaning ascribed to it in  30 
NRS 202.4437. 31 
 [(e)] (f) “Weapon of mass destruction” has the meaning 32 
ascribed to it in NRS 202.4445. 33 
 Sec. 30.  NRS 633.471 is hereby amended to read as follows: 34 
 633.471 1.  Except as otherwise provided in subsection [14] 35 
15 and NRS 633.491, every holder of a license, except a physician 36 
assistant, issued under this chapter, except a temporary or a special 37 
license, may renew the license on or before January 1 of each 38 
calendar year after its issuance by: 39 
 (a) Applying for renewal on forms provided by the Board; 40 
 (b) Paying the annual license renewal fee specified in this 41 
chapter; 42 
 (c) Submitting a list of all actions filed or claims submitted to 43 
arbitration or mediation for malpractice or negligence against the 44 
holder during the previous year; 45   
 	– 38 – 
 
 
- 	*SB439* 
 (d) Subject to subsection [13,] 14, submitting evidence to the 1 
Board that in the year preceding the application for renewal the 2 
holder has attended courses or programs of continuing education 3 
approved by the Board in accordance with regulations adopted by 4 
the Board totaling a number of hours established by the Board 5 
which must not be less than 35 hours nor more than that set in the 6 
requirements for continuing medical education of the American 7 
Osteopathic Association; and 8 
 (e) Submitting all information required to complete the renewal. 9 
 2.  The Secretary of the Board shall notify each licensee of the 10 
requirements for renewal not less than 30 days before the date of 11 
renewal. 12 
 3.  The Board shall request submission of verified evidence of 13 
completion of the required number of hours of continuing medical 14 
education annually from no fewer than one-third of the applicants 15 
for renewal of a license to practice osteopathic medicine or a license 16 
to practice as a physician assistant. Subject to subsection [13,] 14, 17 
upon a request from the Board, an applicant for renewal of a license 18 
to practice osteopathic medicine or a license to practice as a 19 
physician assistant shall submit verified evidence satisfactory to the 20 
Board that in the year preceding the application for renewal the 21 
applicant attended courses or programs of continuing medical 22 
education approved by the Board totaling the number of hours 23 
established by the Board. 24 
 4.  The Board shall require each holder of a license to practice 25 
osteopathic medicine to complete a course of instruction within 2 26 
years after initial licensure that provides at least 2 hours of 27 
instruction on evidence-based suicide prevention and awareness as 28 
described in subsection 9. 29 
 5.  The Board shall encourage each holder of a license to 30 
practice osteopathic medicine to receive, as a portion of his or her 31 
continuing education, training concerning methods for educating 32 
patients about how to effectively manage medications, including, 33 
without limitation, the ability of the patient to request to have the 34 
symptom or purpose for which a drug is prescribed included on the 35 
label attached to the container of the drug. 36 
 6. The Board shall encourage each holder of a license to 37 
practice osteopathic medicine or as a physician assistant to receive, 38 
as a portion of his or her continuing education, training and 39 
education in the diagnosis of rare diseases, including, without 40 
limitation: 41 
 (a) Recognizing the symptoms of pediatric cancer; and  42 
 (b) Interpreting family history to determine whether such 43 
symptoms indicate a normal childhood illness or a condition that 44 
requires additional examination. 45   
 	– 39 – 
 
 
- 	*SB439* 
 7. The Board shall require, as part of the continuing education 1 
requirements approved by the Board, the biennial completion by a 2 
holder of a license to practice osteopathic medicine of at least 2 3 
hours of continuing education credits in ethics, pain management, 4 
care of persons with addictive disorders or the screening, brief 5 
intervention and referral to treatment approach to substance use 6 
disorder. 7 
 8.  The continuing education requirements approved by the 8 
Board must allow the holder of a license as an osteopathic physician 9 
or physician assistant to receive credit toward the total amount of 10 
continuing education required by the Board for the completion of a 11 
course of instruction relating to genetic counseling and genetic 12 
testing. 13 
 9.  The Board shall require each holder of a license to practice 14 
osteopathic medicine to receive as a portion of his or her continuing 15 
education at least 2 hours of instruction every 4 years on evidence-16 
based suicide prevention and awareness which may include, without 17 
limitation, instruction concerning: 18 
 (a) The skills and knowledge that the licensee needs to detect 19 
behaviors that may lead to suicide, including, without limitation, 20 
post-traumatic stress disorder; 21 
 (b) Approaches to engaging other professionals in suicide 22 
intervention; and 23 
 (c) The detection of suicidal thoughts and ideations and the 24 
prevention of suicide. 25 
 10. A holder of a license to practice osteopathic medicine may 26 
not substitute the continuing education credits relating to suicide 27 
prevention and awareness required by this section for the purposes 28 
of satisfying an equivalent requirement for continuing education in 29 
ethics. 30 
 11. The Board shall require each holder of a license to practice 31 
osteopathic medicine to complete at least 2 hours of training in the 32 
screening, brief intervention and referral to treatment approach to 33 
substance use disorder within 2 years after initial licensure. 34 
 12.  The Board shall require each psychiatrist or a physician 35 
assistant practicing under the supervision of a psychiatrist to 36 
biennially complete one or more courses of instruction that provide 37 
at least 2 hours of instruction relating to cultural competency and 38 
diversity, equity and inclusion. Such instruction:  39 
 (a) May include the training provided pursuant to NRS 449.103, 40 
where applicable.  41 
 (b) Must be based upon a range of research from diverse 42 
sources. 43 
 (c) Must address persons of different cultural backgrounds, 44 
including, without limitation:  45   
 	– 40 – 
 
 
- 	*SB439* 
  (1) Persons from various gender, racial and ethnic 1 
backgrounds;  2 
  (2) Persons from various religious backgrounds;  3 
  (3) Lesbian, gay, bisexual, transgender and questioning 4 
persons;  5 
  (4) Children and senior citizens;  6 
  (5) Veterans;  7 
  (6) Persons with a mental illness;  8 
  (7) Persons with an intellectual disability, developmental 9 
disability or physical disability; and  10 
  (8) Persons who are part of any other population that a 11 
psychiatrist or physician assistant practicing under the supervision 12 
of a psychiatrist may need to better understand, as determined by the 13 
Board. 14 
 13.  The Board shall require each holder of a license to 15 
practice osteopathic medicine or as a physician assistant who 16 
provides or supervises the provision of emergency medical services 17 
in a hospital or primary care to complete at least 2 hours of 18 
training in the stigma, discrimination and unrecognized bias 19 
toward persons who have acquired or are at a high risk of 20 
acquiring human immunodeficiency virus within 2 years after 21 
beginning to provide or supervise the provision of such services or 22 
care. 23 
 14. The Board shall not require a physician assistant to receive 24 
or maintain certification by the National Commission on 25 
Certification of Physician Assistants, or its successor organization, 26 
or by any other nationally recognized organization for the 27 
accreditation of physician assistants to satisfy any continuing 28 
education requirement pursuant to paragraph (d) of subsection 1 and 29 
subsection 3. 30 
 [14.] 15.  Members of the Armed Forces of the United States 31 
and the United States Public Health Service are exempt from 32 
payment of the annual license renewal fee during their active duty 33 
status. 34 
 16. As used in this section, “primary care” means the practice 35 
of family medicine, pediatrics, internal medicine, obstetrics and 36 
gynecology and midwifery.  37 
 Sec. 31.  NRS 687B.225 is hereby amended to read as follows: 38 
 687B.225 1.  Except as otherwise provided in NRS 39 
689A.0405, 689A.0412, 689A.0413, 689A.0437, 689A.044, 40 
689A.0445, 689B.031, 689B.0312, 689B.0313, 689B.0315, 41 
689B.0317, 689B.0374, 689C.1671, 689C.1675, 695A.1843, 42 
695A.1856, 695B.1912, 695B.1913, 695B.1914, 695B.1924, 43 
695B.1925, 695B.1942, 695C.1713, 695C.1735, 695C.1737, 44 
695C.1743, 695C.1745, 695C.1751, 695G.170, 695G.1705, 45   
 	– 41 – 
 
 
- 	*SB439* 
695G.171, 695G.1714 and 695G.177, and sections 33, 41, 46, 54, 1 
59, 64 and 71 of this act, any contract for group, blanket or 2 
individual health insurance or any contract by a nonprofit hospital, 3 
medical or dental service corporation or organization for dental care 4 
which provides for payment of a certain part of medical or dental 5 
care may require the insured or member to obtain prior authorization 6 
for that care from the insurer or organization. The insurer or 7 
organization shall: 8 
 (a) File its procedure for obtaining approval of care pursuant to 9 
this section for approval by the Commissioner; and 10 
 (b) Respond to any request for approval by the insured or 11 
member pursuant to this section within 20 days after it receives the 12 
request. 13 
 2.  The procedure for prior authorization may not discriminate 14 
among persons licensed to provide the covered care. 15 
 Sec. 32.  Chapter 689A of NRS is hereby amended by adding 16 
thereto the provisions set forth as sections 33, 34 and 35 of this act. 17 
 Sec. 33.  1. An insurer that offers or issues a policy of 18 
health insurance shall include in the policy coverage for: 19 
 (a) All drugs approved by the United States Food and Drug 20 
Administration to: 21 
  (1) Provide medication-assisted treatment for opioid use 22 
disorder, including, without limitation, buprenorphine, methadone 23 
and naltrexone. 24 
  (2) Support safe withdrawal from substance use disorder, 25 
including, without limitation, lofexidine. 26 
 (b) Any service for the treatment of substance use disorder 27 
provided by a provider of primary care if the service is covered 28 
when provided by a specialist and: 29 
  (1) The service is within the scope of practice of the 30 
provider of primary care; or  31 
  (2) The provider of primary care is capable of providing the 32 
service safely and effectively in consultation with a specialist and 33 
the provider engages in such consultation. 34 
 2. An insurer shall provide the coverage required by 35 
paragraph (a) of subsection 1 regardless of whether the drug is 36 
included in the formulary of the insurer. 37 
 3. An insurer shall not: 38 
 (a) Subject the benefits required by paragraph (a) of 39 
subsection 1 to medical management techniques, other than step 40 
therapy;  41 
 (b) Limit the covered amount of a drug described in paragraph 42 
(a) of subsection 1; or 43   
 	– 42 – 
 
 
- 	*SB439* 
 (c) Refuse to cover a drug described in paragraph (a) of 1 
subsection 1 because the drug is dispensed by a pharmacy through 2 
mail order service. 3 
 4. An insurer shall ensure that the benefits required by 4 
subsection 1 are made available to an insured through a provider 5 
of health care who participates in the network plan of the insurer.  6 
 5.  A policy of health insurance subject to the provisions of 7 
this chapter that is delivered, issued for delivery or renewed on or 8 
after January 1, 2024, has the legal effect of including the 9 
coverage required by subsection 1, and any provision of the policy 10 
that conflicts with the provisions of this section is void.  11 
 6. As used in this section:  12 
 (a) “Medical management technique” means a practice which 13 
is used to control the cost or use of health care services or 14 
prescription drugs. The term includes, without limitation, the use 15 
of step therapy, prior authorization and categorizing drugs and 16 
devices based on cost, type or method of administration. 17 
 (b) “Network plan” means a policy of health insurance offered 18 
by an insurer under which the financing and delivery of medical 19 
care, including items and services paid for as medical care, are 20 
provided, in whole or in part, through a defined set of providers 21 
under contract with the insurer. The term does not include an 22 
arrangement for the financing of premiums.  23 
 (c) “Primary care” means the practice of family medicine, 24 
pediatrics, internal medicine, obstetrics and gynecology and 25 
midwifery.  26 
 (d) “Provider of health care” has the meaning ascribed to it in 27 
NRS 629.031. 28 
 Sec. 34.  1. An insurer that offers or issues a policy of 29 
health insurance shall include in the policy: 30 
 (a) Coverage of testing for and the treatment and prevention of 31 
sexually transmitted diseases, including, without limitation, 32 
Chlamydia trachomatis, gonorrhea, syphilis, human 33 
immunodeficiency virus and hepatitis B and C, for all insureds, 34 
regardless of age. Such coverage must include, without limitation, 35 
the coverage required by NRS 689A.0412 and 689A.0437. 36 
 (b) Unrestricted coverage of condoms for insureds who are 13 37 
years of age or older. 38 
 2. A policy of health insurance subject to the provisions of 39 
this chapter that is delivered, issued for delivery or renewed on or 40 
after January 1, 2024, has the legal effect of including the 41 
coverage required by subsection 1, and any provision of the policy 42 
that conflicts with the provisions of this section is void.  43 
 Sec. 35.  1. A policy of health insurance which provides 44 
coverage for prescription drugs must provide that, when 45   
 	– 43 – 
 
 
- 	*SB439* 
calculating the amount of the contribution by an insured towards 1 
a deductible, copayment, coinsurance or any other cost-sharing 2 
requirement for prescription drugs, the insurer or any pharmacy 3 
benefit manager that manages pharmacy benefits for the insurer 4 
must include the amount paid by the insured or another person or 5 
entity on behalf of the insured for a prescription drug: 6 
 (a) That has no generic equivalent;  7 
 (b) For which the insurer or pharmacy benefit manager has 8 
imposed a requirement for prior authorization or a step therapy 9 
protocol;  10 
 (c) Which is only covered under the policy of health insurance 11 
after the insured: 12 
  (1) Obtains an exception to a general policy of the insurer 13 
or pharmacy benefit manager; or  14 
  (2) Wins an appeal of such a policy; or 15 
 (d) That is prescribed to: 16 
  (1) Prevent the acquisition of human immunodeficiency 17 
virus; 18 
  (2) Treat human immunodeficiency virus or hepatitis C; 19 
  (3) Provide medication-assisted treatment for opioid use 20 
disorder; or 21 
  (4) Support safe withdrawal from substance use disorder. 22 
 2. A policy of health insurance subject to the provisions of 23 
this chapter that is delivered, issued for delivery or renewed on or 24 
after January 1, 2024, has the legal effect of including the 25 
provisions required by subsection 1, and any provision of the 26 
policy that conflicts with the provisions of this section is void.  27 
 3. As used in this section, “pharmacy benefit manager” has 28 
the meaning ascribed to it in NRS 683A.174. 29 
 Sec. 36.  NRS 689A.030 is hereby amended to read as follows: 30 
 689A.030 A policy of health insurance must not be delivered 31 
or issued for delivery to any person in this State unless it otherwise 32 
complies with this Code, and complies with the following: 33 
 1.  The entire money and other considerations for the policy 34 
must be expressed therein. 35 
 2.  The time when the insurance takes effect and terminates 36 
must be expressed therein. 37 
 3.  It must purport to insure only one person, except that a 38 
policy may insure, originally or by subsequent amendment, upon the 39 
application of an adult member of a family, who shall be deemed the 40 
policyholder, any two or more eligible members of that family, 41 
including the husband, wife, domestic partner as defined in NRS 42 
122A.030, dependent children, from the time of birth, adoption or 43 
placement for the purpose of adoption as provided in NRS 44 
689A.043, or any child on or before the last day of the month in 45   
 	– 44 – 
 
 
- 	*SB439* 
which the child attains 26 years of age, and any other person 1 
dependent upon the policyholder. 2 
 4.  The style, arrangement and overall appearance of the policy 3 
must not give undue prominence to any portion of the text, and 4 
every printed portion of the text of the policy and of any 5 
endorsements or attached papers must be plainly printed in light-6 
faced type of a style in general use, the size of which must be 7 
uniform and not less than 10 points with a lowercase unspaced 8 
alphabet length not less than 120 points. “Text” includes all printed 9 
matter except the name and address of the insurer, the name or the 10 
title of the policy, the brief description, if any, and captions and 11 
subcaptions. 12 
 5.  The exceptions and reductions of indemnity must be set 13 
forth in the policy and, other than those contained in NRS 689A.050 14 
to 689A.290, inclusive, must be printed, at the insurer’s option, with 15 
the benefit provision to which they apply or under an appropriate 16 
caption such as “Exceptions” or “Exceptions and Reductions,” 17 
except that if an exception or reduction specifically applies only to a 18 
particular benefit of the policy, a statement of that exception or 19 
reduction must be included with the benefit provision to which it 20 
applies. 21 
 6.  Each such form, including riders and endorsements, must be 22 
identified by a number in the lower left-hand corner of the first page 23 
thereof. 24 
 7.  The policy must not contain any provision purporting to 25 
make any portion of the charter, rules, constitution or bylaws of the 26 
insurer a part of the policy unless that portion is set forth in full in 27 
the policy, except in the case of the incorporation of or reference to 28 
a statement of rates or classification of risks, or short-rate table filed 29 
with the Commissioner. 30 
 8.  The policy must provide benefits for expense arising from 31 
care at home or health supportive services if that care or service was 32 
prescribed by a physician and would have been covered by the 33 
policy if performed in a medical facility or facility for the dependent 34 
as defined in chapter 449 of NRS. 35 
 9.  [The] Except as otherwise provided in this subsection, the 36 
policy must provide [, at the option of the applicant,] benefits for 37 
expenses incurred for the treatment of alcohol or substance use 38 
disorder . [, unless] Except for the benefits required by section 34 39 
of this act, such benefits must be provided: 40 
 (a) At the option of the applicant; and 41 
 (b) Unless the policy provides coverage only for a specified 42 
disease or provides for the payment of a specific amount of money 43 
if the insured is hospitalized or receiving health care in his or her 44 
home. 45   
 	– 45 – 
 
 
- 	*SB439* 
 10.  The policy must provide benefits for expense arising from 1 
hospice care. 2 
 Sec. 37.  NRS 689A.0437 is hereby amended to read as 3 
follows: 4 
 689A.0437 1. An insurer that offers or issues a policy of 5 
health insurance shall include in the policy coverage for:  6 
 (a) [Drugs] All drugs approved by the United States Food and 7 
Drug Administration for preventing the acquisition of human 8 
immunodeficiency virus [;] or treating human immunodeficiency 9 
virus or hepatitis C in the form recommended by the prescribing 10 
practitioner, regardless of whether the drug is included in the 11 
formulary of the insurer; 12 
 (b) Laboratory testing that is necessary for therapy that uses 13 
[such] a drug [;] to prevent the acquisition of human 14 
immunodeficiency virus;  15 
 (c) Any service to test for, prevent or treat human 16 
immunodeficiency virus or hepatitis C provided by a provider of 17 
primary care if the service is covered when provided by a specialist 18 
and: 19 
  (1) The service is within the scope of practice of the 20 
provider of primary care; or  21 
  (2) The provider of primary care is capable of providing the 22 
service safely and effectively in consultation with a specialist and 23 
the provider engages in such consultation; and  24 
 [(c)] (d) The services described in NRS 639.28085, when 25 
provided by a pharmacist who participates in the network plan of the 26 
insurer.  27 
 2. An insurer that offers or issues a policy of health insurance 28 
shall reimburse [a] : 29 
 (a) A pharmacist who participates in the network plan of the 30 
insurer for the services described in NRS 639.28085 at a rate equal 31 
to the rate of reimbursement provided to a physician, physician 32 
assistant or advanced practice registered nurse for similar services.  33 
 (b) An advanced practice registered nurse or a physician 34 
assistant who participates in the network plan of the insurer for 35 
any service to test for, prevent or treat human immunodeficiency 36 
virus or hepatitis C at a rate equal to the rate of reimbursement 37 
provided to a physician for similar services. 38 
 3. An insurer [may subject] shall not: 39 
 (a) Subject the benefits required by subsection 1 to [reasonable] 40 
medical management techniques [.] , other than step therapy;  41 
 (b) Limit the covered amount of a drug described in paragraph 42 
(a) of subsection 1; 43   
 	– 46 – 
 
 
- 	*SB439* 
 (c) Refuse to cover a drug described in paragraph (a) of 1 
subsection 1 because the drug is dispensed by a pharmacy through 2 
mail order service; or 3 
 (d) Prohibit or restrict access to any service or drug to treat 4 
human immunodeficiency virus or hepatitis C on the same day on 5 
which the insured is diagnosed. 6 
 4. An insurer shall ensure that the benefits required by 7 
subsection 1 are made available to an insured through a provider of 8 
health care who participates in the network plan of the insurer.  9 
 5.  A policy of health insurance subject to the provisions of this 10 
chapter that is delivered, issued for delivery or renewed on or after 11 
[October] January 1, [2021,] 2024, has the legal effect of including 12 
the coverage required by subsection 1, and any provision of the 13 
policy that conflicts with the provisions of this section is void.  14 
 6. As used in this section:  15 
 (a) “Medical management technique” means a practice which is 16 
used to control the cost or use of health care services or prescription 17 
drugs. The term includes, without limitation, the use of step therapy, 18 
prior authorization and categorizing drugs and devices based on 19 
cost, type or method of administration. 20 
 (b) “Network plan” means a policy of health insurance offered 21 
by an insurer under which the financing and delivery of medical 22 
care, including items and services paid for as medical care, are 23 
provided, in whole or in part, through a defined set of providers 24 
under contract with the insurer. The term does not include an 25 
arrangement for the financing of premiums.  26 
 (c) “Primary care” means the practice of family medicine, 27 
pediatrics, internal medicine, obstetrics and gynecology and 28 
midwifery.  29 
 (d) “Provider of health care” has the meaning ascribed to it in 30 
NRS 629.031. 31 
 Sec. 38.  NRS 689A.046 is hereby amended to read as follows: 32 
 689A.046 1.  [The] In addition to the benefits required by 33 
section 33 of this act, the benefits provided by a policy for health 34 
insurance for treatment of alcohol or substance use disorder must 35 
[consist of:] include, without limitation: 36 
 (a) Treatment for withdrawal from the physiological effect of 37 
alcohol or drugs, with a minimum benefit of $1,500 per calendar 38 
year. 39 
 (b) Treatment for a patient admitted to a facility, with a 40 
minimum benefit of $9,000 per calendar year. 41 
 (c) Counseling for a person, group or family who is not admitted 42 
to a facility, with a minimum benefit of $2,500 per calendar year. 43   
 	– 47 – 
 
 
- 	*SB439* 
 2.  Except as otherwise provided in NRS 687B.409, these 1 
benefits must be paid in the same manner as benefits for any other 2 
illness covered by a similar policy are paid. 3 
 3.  The insured person is entitled to these benefits if treatment is 4 
received in any: 5 
 (a) Facility for the treatment of alcohol or substance use disorder 6 
which is certified by the Division of Public and Behavioral Health 7 
of the Department of Health and Human Services. 8 
 (b) Hospital or other medical facility or facility for the 9 
dependent which is licensed by the Division of Public and 10 
Behavioral Health of the Department of Health and Human 11 
Services, accredited by The Joint Commission or CARF 12 
International and provides a program for the treatment of alcohol or 13 
substance use disorder as part of its accredited activities. 14 
 Sec. 39.  NRS 689A.330 is hereby amended to read as follows: 15 
 689A.330 If any policy is issued by a domestic insurer for 16 
delivery to a person residing in another state, and if the insurance 17 
commissioner or corresponding public officer of that other state has 18 
informed the Commissioner that the policy is not subject to approval 19 
or disapproval by that officer, the Commissioner may by ruling 20 
require that the policy meet the standards set forth in NRS 689A.030 21 
to 689A.320, inclusive [.] , and sections 33, 34 and 35 of this act. 22 
 Sec. 40.  Chapter 689B of NRS is hereby amended by adding 23 
thereto the provisions set forth as sections 41, 42 and 43 of this act. 24 
 Sec. 41.  1. An insurer that offers or issues a policy of 25 
group health insurance shall include in the policy coverage for: 26 
 (a) All drugs approved by the United States Food and Drug 27 
Administration to: 28 
  (1) Provide medication-assisted treatment for opioid use 29 
disorder, including, without limitation, buprenorphine, methadone 30 
and naltrexone. 31 
  (2) Support safe withdrawal from substance use disorder, 32 
including, without limitation, lofexidine. 33 
 (b) Any service for the treatment of substance use disorder 34 
provided by a provider of primary care if the service is covered 35 
when provided by a specialist and: 36 
  (1) The service is within the scope of practice of the 37 
provider of primary care; or  38 
  (2) The provider of primary care is capable of providing the 39 
service safely and effectively in consultation with a specialist and 40 
the provider engages in such consultation. 41 
 2. An insurer shall provide the coverage required by 42 
paragraph (a) of subsection 1 regardless of whether the drug is 43 
included in the formulary of the insurer. 44 
 3. An insurer shall not: 45   
 	– 48 – 
 
 
- 	*SB439* 
 (a) Subject the benefits required by paragraph (a) of 1 
subsection 1 to medical management techniques, other than step 2 
therapy;  3 
 (b) Limit the covered amount of a drug described in paragraph 4 
(a) of subsection 1; or 5 
 (c) Refuse to cover a drug described in paragraph (a) of 6 
subsection 1 because the drug is dispensed by a pharmacy through 7 
mail order service. 8 
 4. An insurer shall ensure that the benefits required by 9 
subsection 1 are made available to an insured through a provider 10 
of health care who participates in the network plan of the insurer.  11 
 5.  A policy of group health insurance subject to the 12 
provisions of this chapter that is delivered, issued for delivery or 13 
renewed on or after January 1, 2024, has the legal effect of 14 
including the coverage required by subsection 1, and any 15 
provision of the policy that conflicts with the provisions of this 16 
section is void.  17 
 6. As used in this section:  18 
 (a) “Medical management technique” means a practice which 19 
is used to control the cost or use of health care services or 20 
prescription drugs. The term includes, without limitation, the use 21 
of step therapy, prior authorization and categorizing drugs and 22 
devices based on cost, type or method of administration. 23 
 (b) “Network plan” means a policy of group health insurance 24 
offered by an insurer under which the financing and delivery of 25 
medical care, including items and services paid for as medical 26 
care, are provided, in whole or in part, through a defined set of 27 
providers under contract with the insurer. The term does not 28 
include an arrangement for the financing of premiums.  29 
 (c) “Primary care” means the practice of family medicine, 30 
pediatrics, internal medicine, obstetrics and gynecology and 31 
midwifery.  32 
 (d) “Provider of health care” has the meaning ascribed to it in 33 
NRS 629.031. 34 
 Sec. 42.  1. An insurer that offers or issues a policy of 35 
group health insurance shall include in the policy: 36 
 (a) Coverage of testing for and the treatment of and prevention 37 
of sexually transmitted diseases, including, without limitation, 38 
Chlamydia trachomatis, gonorrhea, syphilis, human 39 
immunodeficiency virus and hepatitis B and C, for all insureds, 40 
regardless of age. Such coverage must include, without limitation, 41 
the coverage required by NRS 689B.0312 and 689B.0315. 42 
 (b) Unrestricted coverage of condoms for insureds who are 13 43 
years of age or older. 44   
 	– 49 – 
 
 
- 	*SB439* 
 2. A policy of group health insurance subject to the 1 
provisions of this chapter that is delivered, issued for delivery or 2 
renewed on or after January 1, 2024, has the legal effect of 3 
including the coverage required by subsection 1, and any 4 
provision of the policy that conflicts with the provisions of this 5 
section is void.  6 
 Sec. 43.  1. A policy of group health insurance which 7 
provides coverage for prescription drugs must provide that, when 8 
calculating the amount of the contribution by an insured towards 9 
a deductible, copayment, coinsurance or any other cost-sharing 10 
requirement for prescription drugs, the insurer or any pharmacy 11 
benefit manager that manages pharmacy benefits for the insurer 12 
must include the amount paid by the insured or another person or 13 
entity on behalf of the insured for a prescription drug: 14 
 (a) That has no generic equivalent;  15 
 (b) For which the insurer or pharmacy benefit manager has 16 
imposed a requirement for prior authorization or a step therapy 17 
protocol; 18 
 (c) Which is only covered under the policy of group health 19 
insurance after the insured: 20 
  (1) Obtains an exception to a general policy of the insurer 21 
or pharmacy benefit manager; or  22 
  (2) Wins an appeal of such a policy; or 23 
 (d) That is prescribed to: 24 
  (1) Prevent the acquisition of human immunodeficiency 25 
virus; 26 
  (2) Treat human immunodeficiency virus or hepatitis C; 27 
  (3) Provide medication-assisted treatment for opioid use 28 
disorder; or 29 
  (4) Support safe withdrawal from substance use disorder. 30 
 2. A policy of group health insurance subject to the 31 
provisions of this chapter that is delivered, issued for delivery or 32 
renewed on or after January 1, 2024, has the legal effect of 33 
including the provisions required by subsection 1, and any 34 
provision of the policy that conflicts with the provisions of this 35 
section is void.  36 
 3. As used in this section, “pharmacy benefit manager” has 37 
the meaning ascribed to it in NRS 683A.174. 38 
 Sec. 44.  NRS 689B.0312 is hereby amended to read as 39 
follows: 40 
 689B.0312 1. An insurer that offers or issues a policy of 41 
group health insurance shall include in the policy coverage for:  42 
 (a) [Drugs] All drugs approved by the United States Food and 43 
Drug Administration for preventing the acquisition of human 44 
immunodeficiency virus [;] or treating human immunodeficiency 45   
 	– 50 – 
 
 
- 	*SB439* 
virus or hepatitis C in the form recommended by the prescribing 1 
practitioner, regardless of whether the drug is included in the 2 
formulary of the insurer; 3 
 (b) Laboratory testing that is necessary for therapy that uses 4 
[such] a drug [;] to prevent the acquisition of human 5 
immunodeficiency virus;  6 
 (c) Any service to test for, prevent or treat human 7 
immunodeficiency virus or hepatitis C provided by a provider of 8 
primary care if the service is covered when provided by a specialist 9 
and: 10 
  (1) The service is within the scope of practice of the 11 
provider of primary care; or  12 
  (2) The provider of primary care is capable of providing the 13 
service safely and effectively in consultation with a specialist and 14 
the provider engages in such consultation; and  15 
 [(c)] (d) The services described in NRS 639.28085, when 16 
provided by a pharmacist who participates in the network plan of the 17 
insurer.  18 
 2. An insurer that offers or issues a policy of group health 19 
insurance shall reimburse [a] : 20 
 (a) A pharmacist who participates in the network plan of the 21 
insurer for the services described in NRS 639.28085 at a rate equal 22 
to the rate of reimbursement provided to a physician, physician 23 
assistant or advanced practice registered nurse for similar services.  24 
 (b) An advanced practice registered nurse or a physician 25 
assistant who participates in the network plan of the insurer for 26 
any service to test for, prevent or treat human immunodeficiency 27 
virus or hepatitis C at a rate equal to the rate of reimbursement 28 
provided to a physician for similar services. 29 
 3. An insurer [may subject] shall not: 30 
 (a) Subject the benefits required by subsection 1 to [reasonable] 31 
medical management techniques [.] , other than step therapy;  32 
 (b) Limit the covered amount of a drug described in paragraph 33 
(a) of subsection 1; 34 
 (c) Refuse to cover a drug described in paragraph (a) of 35 
subsection 1 because the drug is dispensed by a pharmacy through 36 
mail order service; or 37 
 (d) Prohibit or restrict access to any service or drug to treat 38 
human immunodeficiency virus or hepatitis C on the same day on 39 
which the insured is diagnosed. 40 
 4. An insurer shall ensure that the benefits required by 41 
subsection 1 are made available to an insured through a provider of 42 
health care who participates in the network plan of the insurer.  43 
 5. A policy of group health insurance subject to the provisions 44 
of this chapter that is delivered, issued for delivery or renewed on or 45   
 	– 51 – 
 
 
- 	*SB439* 
after [October] January 1, [2021,] 2024, has the legal effect of 1 
including the coverage required by subsection 1, and any provision 2 
of the policy that conflicts with the provisions of this section is void.  3 
 6. As used in this section:  4 
 (a) “Medical management technique” means a practice which is 5 
used to control the cost or use of health care services or prescription 6 
drugs. The term includes, without limitation, the use of step therapy, 7 
prior authorization and categorizing drugs and devices based on 8 
cost, type or method of administration. 9 
 (b) “Network plan” means a policy of group health insurance 10 
offered by an insurer under which the financing and delivery of 11 
medical care, including items and services paid for as medical care, 12 
are provided, in whole or in part, through a defined set of providers 13 
under contract with the insurer. The term does not include an 14 
arrangement for the financing of premiums.  15 
 (c) “Primary care” means the practice of family medicine, 16 
pediatrics, internal medicine, obstetrics and gynecology and 17 
midwifery.  18 
 (d) “Provider of health care” has the meaning ascribed to it in 19 
NRS 629.031. 20 
 Sec. 45.  Chapter 689C of NRS is hereby amended by adding 21 
thereto the provisions set forth as sections 46, 47 and 48 of this act. 22 
 Sec. 46.  1. A carrier that offers or issues a health benefit 23 
plan shall include in the plan coverage for: 24 
 (a) All drugs approved by the United States Food and Drug 25 
Administration to: 26 
  (1) Provide medication-assisted treatment for opioid use 27 
disorder, including, without limitation, buprenorphine, methadone 28 
and naltrexone. 29 
  (2) Support safe withdrawal from substance use disorder, 30 
including, without limitation, lofexidine. 31 
 (b) Any service for the treatment of substance use disorder 32 
provided by a provider of primary care if the service is covered 33 
when provided by a specialist and: 34 
  (1) The service is within the scope of practice of the 35 
provider of primary care; or  36 
  (2) The provider of primary care is capable of providing the 37 
service safely and effectively in consultation with a specialist and 38 
the provider engages in such consultation. 39 
 2. A carrier shall provide the coverage required by paragraph 40 
(a) of subsection 1 regardless of whether the drug is included in 41 
the formulary of the carrier. 42 
 3. A carrier shall not: 43   
 	– 52 – 
 
 
- 	*SB439* 
 (a) Subject the benefits required by paragraph (a) of 1 
subsection 1 to medical management techniques, other than step 2 
therapy;  3 
 (b) Limit the covered amount of a drug described in paragraph 4 
(a) of subsection 1; or 5 
 (c) Refuse to cover a drug described in paragraph (a) of 6 
subsection 1 because the drug is dispensed by a pharmacy through 7 
mail order service. 8 
 4. A carrier shall ensure that the benefits required by 9 
subsection 1 are made available to an insured through a provider 10 
of health care who participates in the network plan of the carrier.  11 
 5.  A health benefit plan subject to the provisions of this 12 
chapter that is delivered, issued for delivery or renewed on or after 13 
January 1, 2024, has the legal effect of including the coverage 14 
required by subsection 1, and any provision of the plan that 15 
conflicts with the provisions of this section is void.  16 
 6. As used in this section:  17 
 (a) “Medical management technique” means a practice which 18 
is used to control the cost or use of health care services or 19 
prescription drugs. The term includes, without limitation, the use 20 
of step therapy, prior authorization and categorizing drugs and 21 
devices based on cost, type or method of administration. 22 
 (b) “Network plan” means a health benefit plan offered by a 23 
carrier under which the financing and delivery of medical care, 24 
including items and services paid for as medical care, are 25 
provided, in whole or in part, through a defined set of providers 26 
under contract with the carrier. The term does not include an 27 
arrangement for the financing of premiums.  28 
 (c) “Primary care” means the practice of family medicine, 29 
pediatrics, internal medicine, obstetrics and gynecology and 30 
midwifery.  31 
 (d) “Provider of health care” has the meaning ascribed to it in 32 
NRS 629.031. 33 
 Sec. 47.  1. A carrier that offers or issues a health benefit 34 
plan shall include in the plan: 35 
 (a) Coverage of testing for and the treatment and prevention of 36 
sexually transmitted diseases, including, without limitation, 37 
Chlamydia trachomatis, gonorrhea, syphilis, human 38 
immunodeficiency virus and hepatitis B and C, for all insureds, 39 
regardless of age. Such coverage must include, without limitation, 40 
the coverage required by NRS 689C.1671 and 689C.1675. 41 
 (b) Unrestricted coverage of condoms for insureds who are 13 42 
years of age or older. 43 
 2. A health benefit plan subject to the provisions of this 44 
chapter that is delivered, issued for delivery or renewed on or after 45   
 	– 53 – 
 
 
- 	*SB439* 
January 1, 2024, has the legal effect of including the coverage 1 
required by subsection 1, and any provision of the plan that 2 
conflicts with the provisions of this section is void.  3 
 Sec. 48.  1. A health benefit plan which provides coverage 4 
for prescription drugs must provide that, when calculating the 5 
amount of the contribution by an insured towards a deductible, 6 
copayment, coinsurance or any other cost-sharing requirement for 7 
prescription drugs, the carrier or any pharmacy benefit manager 8 
that manages pharmacy benefits for the carrier must include the 9 
amount paid by the insured or another person or entity on behalf 10 
of the insured for a prescription drug: 11 
 (a) That has no generic equivalent;  12 
 (b) For which the carrier or pharmacy benefit manager has 13 
imposed a requirement for prior authorization or a step therapy 14 
protocol; 15 
 (c) Which is only covered under the health benefit plan after 16 
the insured: 17 
  (1) Obtains an exception to a general policy of the carrier 18 
or pharmacy benefit manager; or  19 
  (2) Wins an appeal of such a policy; or 20 
 (d) That is prescribed to: 21 
  (1) Prevent the acquisition of human immunodeficiency 22 
virus; 23 
  (2) Treat human immunodeficiency virus or hepatitis C; 24 
  (3) Provide medication-assisted treatment for opioid use 25 
disorder; or 26 
  (4) Support safe withdrawal from substance use disorder. 27 
 2. A health benefit plan subject to the provisions of this 28 
chapter that is delivered, issued for delivery or renewed on or after 29 
January 1, 2024, has the legal effect of including the provisions 30 
required by subsection 1, and any provision of the plan that 31 
conflicts with the provisions of this section is void.  32 
 3. As used in this section, “pharmacy benefit manager” has 33 
the meaning ascribed to it in NRS 683A.174. 34 
 Sec. 49.  NRS 689C.166 is hereby amended to read as follows: 35 
 689C.166 Each group health insurance policy must contain in 36 
substance a provision for benefits payable for expenses incurred for 37 
the treatment of alcohol or substance use disorder, as provided in 38 
NRS 689C.167 [.] and section 46 of this act. 39 
 Sec. 50.  NRS 689C.167 is hereby amended to read as follows: 40 
 689C.167 1.  [The] In addition to the benefits required by 41 
section 46 of this act, the benefits provided by a group policy for 42 
health insurance, as required by NRS 689C.166, for the treatment of 43 
alcohol or substance use disorders must [consist of:] include, 44 
without limitation: 45   
 	– 54 – 
 
 
- 	*SB439* 
 (a) Treatment for withdrawal from the physiological effects of 1 
alcohol or drugs, with a minimum benefit of $1,500 per calendar 2 
year. 3 
 (b) Treatment for a patient admitted to a facility, with a 4 
minimum benefit of $9,000 per calendar year. 5 
 (c) Counseling for a person, group or family who is not admitted 6 
to a facility, with a minimum benefit of $2,500 per calendar year. 7 
 2.  Except as otherwise provided in NRS 687B.409, these 8 
benefits must be paid in the same manner as benefits for any other 9 
illness covered by a similar policy are paid. 10 
 3.  The insured person is entitled to these benefits if treatment is 11 
received in any: 12 
 (a) Facility for the treatment of alcohol or substance use 13 
disorders which is certified by the Division of Public and Behavioral 14 
Health of the Department of Health and Human Services. 15 
 (b) Hospital or other medical facility or facility for the 16 
dependent which is licensed by the Division of Public and 17 
Behavioral Health of the Department of Health and Human 18 
Services, is accredited by The Joint Commission or CARF 19 
International and provides a program for the treatment of alcohol or 20 
substance use disorders as part of its accredited activities. 21 
 Sec. 51.  NRS 689C.1671 is hereby amended to read as 22 
follows: 23 
 689C.1671 1.  A carrier that offers or issues a health benefit 24 
plan shall include in the plan coverage for:  25 
 (a) [Drugs] All drugs approved by the United States Food and 26 
Drug Administration for preventing the acquisition of human 27 
immunodeficiency virus [;] or treating human immunodeficiency 28 
virus or hepatitis C in the form recommended by the prescribing 29 
practitioner, regardless of whether the drug is included in the 30 
formulary of the carrier; 31 
 (b) Laboratory testing that is necessary for therapy that uses 32 
[such] a drug [;] to prevent the acquisition of human 33 
immunodeficiency virus;  34 
 (c) Any service to test for, prevent or treat human 35 
immunodeficiency virus or hepatitis C provided by a provider of 36 
primary care if the service is covered when provided by a specialist 37 
and: 38 
  (1) The service is within the scope of practice of the 39 
provider of primary care; or  40 
  (2) The provider of primary care is capable of providing the 41 
service safely and effectively in consultation with a specialist and 42 
the provider engages in such consultation; and  43   
 	– 55 – 
 
 
- 	*SB439* 
 [(c)] (d) The services described in NRS 639.28085, when 1 
provided by a pharmacist who participates in the health benefit plan 2 
of the carrier.  3 
 2.  A carrier that offers or issues a health benefit plan shall 4 
reimburse [a] : 5 
 (a) A pharmacist who participates in the health benefit plan of 6 
the carrier for the services described in NRS 639.28085 at a rate 7 
equal to the rate of reimbursement provided to a physician, 8 
physician assistant or advanced practice registered nurse for similar 9 
services.  10 
 (b) An advanced practice registered nurse or a physician 11 
assistant who participates in the network plan of the carrier for 12 
any service to test for, prevent or treat human immunodeficiency 13 
virus or hepatitis C at a rate equal to the rate of reimbursement 14 
provided to a physician for similar services. 15 
 3.  A carrier [may subject] shall not: 16 
 (a) Subject the benefits required by subsection 1 to [reasonable] 17 
medical management techniques [.] , other than step therapy;  18 
 (b) Limit the covered amount of a drug described in paragraph 19 
(a) of subsection 1; 20 
 (c) Refuse to cover a drug described in paragraph (a) of 21 
subsection 1 because the drug is dispensed by a pharmacy through 22 
mail order service; or 23 
 (d) Prohibit or restrict access to any service or drug to treat 24 
human immunodeficiency virus or hepatitis C on the same day on 25 
which the insured is diagnosed. 26 
 4.  A carrier shall ensure that the benefits required by 27 
subsection 1 are made available to an insured through a provider of 28 
health care who participates in the network plan of the carrier.  29 
 5.  A health benefit plan subject to the provisions of this chapter 30 
that is delivered, issued for delivery or renewed on or after 31 
[October] January 1, [2021,] 2024, has the legal effect of including 32 
the coverage required by subsection 1, and any provision of the plan 33 
that conflicts with the provisions of this section is void.  34 
 6.  As used in this section:  35 
 (a) “Medical management technique” means a practice which is 36 
used to control the cost or use of health care services or prescription 37 
drugs. The term includes, without limitation, the use of step therapy, 38 
prior authorization and categorizing drugs and devices based on 39 
cost, type or method of administration. 40 
 (b) “Network plan” means a health benefit plan offered by a 41 
carrier under which the financing and delivery of medical care, 42 
including items and services paid for as medical care, are provided, 43 
in whole or in part, through a defined set of providers under contract 44   
 	– 56 – 
 
 
- 	*SB439* 
with the carrier. The term does not include an arrangement for the 1 
financing of premiums.  2 
 (c) “Primary care” means the practice of family medicine, 3 
pediatrics, internal medicine, obstetrics and gynecology and 4 
midwifery.  5 
 (d) “Provider of health care” has the meaning ascribed to it in 6 
NRS 629.031. 7 
 Sec. 52.  NRS 689C.425 is hereby amended to read as follows: 8 
 689C.425 A voluntary purchasing group and any contract 9 
issued to such a group pursuant to NRS 689C.360 to 689C.600, 10 
inclusive, are subject to the provisions of NRS 689C.015 to 11 
689C.355, inclusive, and sections 46, 47 and 48 of this act to the 12 
extent applicable and not in conflict with the express provisions of 13 
NRS 687B.408 and 689C.360 to 689C.600, inclusive. 14 
 Sec. 53.  Chapter 695A of NRS is hereby amended by adding 15 
thereto the provisions set forth as sections 54, 55 and 56 of this act. 16 
 Sec. 54.  1. A society that offers or issues a benefit contract 17 
shall include in the contract coverage for: 18 
 (a) All drugs approved by the United States Food and Drug 19 
Administration to: 20 
  (1) Provide medication-assisted treatment for opioid use 21 
disorder, including, without limitation, buprenorphine, methadone 22 
and naltrexone. 23 
  (2) Support safe withdrawal from substance use disorder, 24 
including, without limitation, lofexidine. 25 
 (b) Any service for the treatment of substance use disorder 26 
provided by a provider of primary care if the service is covered 27 
when provided by a specialist and: 28 
  (1) The service is within the scope of practice of the 29 
provider of primary care; or  30 
  (2) The provider of primary care is capable of providing the 31 
service safely and effectively in consultation with a specialist and 32 
the provider engages in such consultation. 33 
 2. A society shall provide the coverage required by paragraph 34 
(a) of subsection 1 regardless of whether the drug is included in 35 
the formulary of the society. 36 
 3. A society shall not: 37 
 (a) Subject the benefits required by paragraph (a) of 38 
subsection 1 to medical management techniques, other than step 39 
therapy;  40 
 (b) Limit the covered amount of a drug described in paragraph 41 
(a) of subsection 1; or 42 
 (c) Refuse to cover a drug described in paragraph (a) of 43 
subsection 1 because the drug is dispensed by a pharmacy through 44 
mail order service. 45   
 	– 57 – 
 
 
- 	*SB439* 
 4. A society shall ensure that the benefits required by 1 
subsection 1 are made available to an insured through a provider 2 
of health care who participates in the network plan of the society.  3 
 5.  A benefit contract subject to the provisions of this chapter 4 
that is delivered, issued for delivery or renewed on or after 5 
January 1, 2024, has the legal effect of including the coverage 6 
required by subsection 1, and any provision of the contract that 7 
conflicts with the provisions of this section is void.  8 
 6. As used in this section:  9 
 (a) “Medical management technique” means a practice which 10 
is used to control the cost or use of health care services or 11 
prescription drugs. The term includes, without limitation, the use 12 
of step therapy, prior authorization and categorizing drugs and 13 
devices based on cost, type or method of administration. 14 
 (b) “Network plan” means a benefit contract offered by a 15 
society under which the financing and delivery of medical care, 16 
including items and services paid for as medical care, are 17 
provided, in whole or in part, through a defined set of providers 18 
under contract with the society. The term does not include an 19 
arrangement for the financing of premiums.  20 
 (c) “Primary care” means the practice of family medicine, 21 
pediatrics, internal medicine, obstetrics and gynecology and 22 
midwifery.  23 
 (d) “Provider of health care” has the meaning ascribed to it in 24 
NRS 629.031. 25 
 Sec. 55.  1. A society that offers or issues a benefit contract 26 
shall include in the contract: 27 
 (a) Coverage of testing for and the treatment and prevention of 28 
sexually transmitted diseases, including, without limitation, 29 
Chlamydia trachomatis, gonorrhea, syphilis, human 30 
immunodeficiency virus and hepatitis B and C, for all insureds, 31 
regardless of age. Such coverage must include, without limitation, 32 
the coverage required by NRS 695A.1843 and 695A.1856. 33 
 (b) Unrestricted coverage of condoms for insureds who are 13 34 
years of age or older. 35 
 2. A benefit contract subject to the provisions of this chapter 36 
that is delivered, issued for delivery or renewed on or after 37 
January 1, 2024, has the legal effect of including the coverage 38 
required by subsection 1, and any provision of the contract that 39 
conflicts with the provisions of this section is void.  40 
 Sec. 56.  1. A benefit contract which provides coverage for 41 
prescription drugs must provide that, when calculating the amount 42 
of the contribution by an insured towards a deductible, copayment, 43 
coinsurance or any other cost-sharing requirement for 44 
prescription drugs, the society or any pharmacy benefit manager 45   
 	– 58 – 
 
 
- 	*SB439* 
that manages pharmacy benefits for the society must include the 1 
amount paid by the insured or another person or entity on behalf 2 
of the insured for a prescription drug: 3 
 (a) That has no generic equivalent;  4 
 (b) For which the society or pharmacy benefit manager has 5 
imposed a requirement for prior authorization or a step therapy 6 
protocol;  7 
 (c) Which is only covered under the benefit contract after the 8 
insured: 9 
  (1) Obtains an exception to a general policy of the society 10 
or pharmacy benefit manager; or  11 
  (2) Wins an appeal of such a policy; or 12 
 (d) That is prescribed to: 13 
  (1) Prevent the acquisition of human immunodeficiency 14 
virus; 15 
  (2) Treat human immunodeficiency virus or hepatitis C; 16 
  (3) Provide medication-assisted treatment for opioid use 17 
disorder; or 18 
  (4) Support safe withdrawal from substance use disorder. 19 
 2. A benefit contract subject to the provisions of this chapter 20 
that is delivered, issued for delivery or renewed on or after 21 
January 1, 2024, has the legal effect of including the provisions 22 
required by subsection 1, and any provision of the contract that 23 
conflicts with the provisions of this section is void.  24 
 3. As used in this section, “pharmacy benefit manager” has 25 
the meaning ascribed to it in NRS 683A.174. 26 
 Sec. 57.  NRS 695A.1843 is hereby amended to read as 27 
follows: 28 
 695A.1843 1. A society that offers or issues a benefit 29 
contract shall include in the benefit coverage for:  30 
 (a) [Drugs] All approved by the United States Food and Drug 31 
Administration for preventing the acquisition of human 32 
immunodeficiency virus [;] or treating human immunodeficiency 33 
virus or hepatitis C in the form recommended by the prescribing 34 
practitioner, regardless of whether the drug is included in the 35 
formulary of the society; 36 
 (b) Laboratory testing that is necessary for therapy that uses 37 
[such] a drug [;] to prevent the acquisition of human 38 
immunodeficiency virus; 39 
 (c) Any service to test for, prevent or treat human 40 
immunodeficiency virus or hepatitis C provided by a provider of 41 
primary care if the service is covered when provided by a specialist 42 
and: 43 
  (1) The service is within the scope of practice of the 44 
provider of primary care; or  45   
 	– 59 – 
 
 
- 	*SB439* 
  (2) The provider of primary care is capable of providing the 1 
service safely and effectively in consultation with a specialist and 2 
the provider engages in such consultation; and  3 
 [(c)] (d) The services described in NRS 639.28085, when 4 
provided by a pharmacist who participates in the network plan of the 5 
society.  6 
 2. A society that offers or issues a benefit contract shall 7 
reimburse [a] :  8 
 (a) A pharmacist who participates in the network plan of the 9 
society for the services described in NRS 639.28085 at a rate equal 10 
to the rate of reimbursement provided to a physician, physician 11 
assistant or advanced practice registered nurse for similar services.  12 
 (b) An advanced practice registered nurse or a physician 13 
assistant who participates in the network plan of the society for 14 
any service to test for, prevent or treat human immunodeficiency 15 
virus or hepatitis C at a rate equal to the rate of reimbursement 16 
provided to a physician for similar services. 17 
 3. A society [may subject] shall not: 18 
 (a) Subject the benefits required by subsection 1 to [reasonable] 19 
medical management techniques [.] , other than step therapy;  20 
 (b) Limit the covered amount of a drug described in paragraph 21 
(a) of subsection 1; 22 
 (c) Refuse to cover a drug described in paragraph (a) of 23 
subsection 1 because the drug is dispensed by a pharmacy through 24 
mail order service; or 25 
 (d) Prohibit or restrict access to any service or drug to treat 26 
human immunodeficiency virus or hepatitis C on the same day on 27 
which the insured is diagnosed. 28 
 4. A society shall ensure that the benefits required by 29 
subsection 1 are made available to an insured through a provider of 30 
health care who participates in the network plan of the society.  31 
 5. A benefit contract subject to the provisions of this chapter 32 
that is delivered, issued for delivery or renewed on or after 33 
[October] January 1, [2021,] 2024, has the legal effect of including 34 
the coverage required by subsection 1, and any provision of the plan 35 
that conflicts with the provisions of this section is void.  36 
 6. As used in this section:  37 
 (a) “Medical management technique” means a practice which is 38 
used to control the cost or use of health care services or prescription 39 
drugs. The term includes, without limitation, the use of step therapy, 40 
prior authorization and categorizing drugs and devices based on 41 
cost, type or method of administration. 42 
 (b) “Network plan” means a benefit contract offered by a society 43 
under which the financing and delivery of medical care, including 44 
items and services paid for as medical care, are provided, in whole 45   
 	– 60 – 
 
 
- 	*SB439* 
or in part, through a defined set of providers under contract with the 1 
society. The term does not include an arrangement for the financing 2 
of premiums.  3 
 (c) “Primary care” means the practice of family medicine, 4 
pediatrics, internal medicine, obstetrics and gynecology and 5 
midwifery.  6 
 (d) “Provider of health care” has the meaning ascribed to it in 7 
NRS 629.031. 8 
 Sec. 58.  Chapter 695B of NRS is hereby amended by adding 9 
thereto the provisions set forth as sections 59, 60 and 61 of this act. 10 
 Sec. 59.  1. A hospital or medical services corporation that 11 
offers or issues a policy of health insurance shall include in the 12 
policy coverage for: 13 
 (a) All drugs approved by the United States Food and Drug 14 
Administration to: 15 
  (1) Provide medication-assisted treatment for opioid use 16 
disorder, including, without limitation, buprenorphine, methadone 17 
and naltrexone. 18 
  (2) Support safe withdrawal from substance use disorder, 19 
including, without limitation, lofexidine. 20 
 (b) Any service for the treatment of substance use disorder 21 
provided by a provider of primary care if the service is covered 22 
when provided by a specialist and: 23 
  (1) The service is within the scope of practice of the 24 
provider of primary care; or  25 
  (2) The provider of primary care is capable of providing the 26 
service safely and effectively in consultation with a specialist and 27 
the provider engages in such consultation. 28 
 2. A hospital or medical services corporation shall provide the 29 
coverage required by paragraph (a) of subsection 1 regardless of 30 
whether the drug is included in the formulary of the hospital or 31 
medical services corporation. 32 
 3. A hospital or medical services corporation shall not: 33 
 (a) Subject the benefits required by paragraph (a) of 34 
subsection 1 to medical management techniques, other than step 35 
therapy;  36 
 (b) Limit the covered amount of a drug described in paragraph 37 
(a) of subsection 1; or 38 
 (c) Refuse to cover a drug described in paragraph (a) of 39 
subsection 1 because the drug is dispensed by a pharmacy through 40 
mail order service. 41 
 4. A hospital or medical services corporation shall ensure 42 
that the benefits required by subsection 1 are made available to an 43 
insured through a provider of health care who participates in the 44 
network plan of the hospital or medical services corporation.  45   
 	– 61 – 
 
 
- 	*SB439* 
 5.  A policy of health insurance subject to the provisions of 1 
this chapter that is delivered, issued for delivery or renewed on or 2 
after January 1, 2024, has the legal effect of including the 3 
coverage required by subsection 1, and any provision of the policy 4 
that conflicts with the provisions of this section is void.  5 
 6. As used in this section:  6 
 (a) “Medical management technique” means a practice which 7 
is used to control the cost or use of health care services or 8 
prescription drugs. The term includes, without limitation, the use 9 
of step therapy, prior authorization and categorizing drugs and 10 
devices based on cost, type or method of administration. 11 
 (b) “Network plan” means a policy of health insurance offered 12 
by a hospital or medical services corporation under which the 13 
financing and delivery of medical care, including items and 14 
services paid for as medical care, are provided, in whole or in part, 15 
through a defined set of providers under contract with the hospital 16 
or medical services corporation. The term does not include an 17 
arrangement for the financing of premiums.  18 
 (c) “Primary care” means the practice of family medicine, 19 
pediatrics, internal medicine, obstetrics and gynecology and 20 
midwifery.  21 
 (d) “Provider of health care” has the meaning ascribed to it in 22 
NRS 629.031. 23 
 Sec. 60.  1. A hospital or medical services corporation that 24 
offers or issues a policy of health insurance shall include in the 25 
policy: 26 
 (a) Coverage of testing for and the treatment and prevention of 27 
sexually transmitted diseases, including, without limitation, 28 
Chlamydia trachomatis, gonorrhea, syphilis, human 29 
immunodeficiency virus and hepatitis B and C, for all insureds, 30 
regardless of age. Such coverage must include, without limitation, 31 
the coverage required by NRS 695B.1913 and 695B.1924. 32 
 (b) Unrestricted coverage of condoms for insureds who are 13 33 
years of age or older. 34 
 2. A policy of health insurance subject to the provisions of 35 
this chapter that is delivered, issued for delivery or renewed on or 36 
after January 1, 2024, has the legal effect of including the 37 
coverage required by subsection 1, and any provision of the policy 38 
that conflicts with the provisions of this section is void.  39 
 Sec. 61.  1. A policy of health insurance which provides 40 
coverage for prescription drugs must provide that, when 41 
calculating the amount of the contribution by an insured towards 42 
a deductible, copayment, coinsurance or any other cost-sharing 43 
requirement for prescription drugs, the hospital or medical 44 
services corporation or any pharmacy benefit manager that 45   
 	– 62 – 
 
 
- 	*SB439* 
manages pharmacy benefits for the hospital or medical services 1 
corporation must include the amount paid by the insured or 2 
another person or entity on behalf of the insured for a prescription 3 
drug: 4 
 (a) That has no generic equivalent;  5 
 (b) For which the hospital or medical services corporation or 6 
pharmacy benefit manager has imposed a requirement for prior 7 
authorization or a step therapy protocol; or 8 
 (c) Which is only covered under the policy of health insurance 9 
after the insured: 10 
  (1) Obtains an exception to a general policy of the hospital 11 
or medical services corporation or pharmacy benefit manager; or  12 
  (2) Wins an appeal of such a policy; or 13 
 (d) That is prescribed to: 14 
  (1) Prevent the acquisition of human immunodeficiency 15 
virus; 16 
  (2) Treat human immunodeficiency virus or hepatitis C; 17 
  (3) Provide medication-assisted treatment for opioid use 18 
disorder; or 19 
  (4) Support safe withdrawal from substance use disorder. 20 
 2. A policy of health insurance subject to the provisions of 21 
this chapter that is delivered, issued for delivery or renewed on or 22 
after January 1, 2024, has the legal effect of including the 23 
provisions required by subsection 1, and any provision of the 24 
policy that conflicts with the provisions of this section is void.  25 
 3. As used in this section, “pharmacy benefit manager” has 26 
the meaning ascribed to it in NRS 683A.174. 27 
 Sec. 62.  NRS 695B.1924 is hereby amended to read as 28 
follows: 29 
 695B.1924 1. A hospital or medical services corporation that 30 
offers or issues a policy of health insurance shall include in the 31 
policy coverage for: 32 
 (a) [Drugs] All drugs approved by the United States Food and 33 
Drug Administration for preventing the acquisition of human 34 
immunodeficiency virus [;] or treating human immunodeficiency 35 
virus or hepatitis C in the form recommended by the prescribing 36 
practitioner, regardless of whether the drug is included in the 37 
formulary of the hospital or medical services organization; 38 
 (b) Laboratory testing that is necessary for therapy using [such] 39 
a drug [;] to prevent the acquisition of human immunodeficiency 40 
virus;  41 
 (c) Any service to test for, prevent or treat human 42 
immunodeficiency virus or hepatitis C provided by a provider of 43 
primary care if the service is covered when provided by a specialist 44 
and: 45   
 	– 63 – 
 
 
- 	*SB439* 
  (1) The service is within the scope of practice of the 1 
provider of primary care; or  2 
  (2) The provider of primary care is capable of providing the 3 
service safely and effectively in consultation with a specialist and 4 
the provider engages in such consultation; and 5 
 [(c)] (d) The services described in NRS 639.28085, when 6 
provided by a pharmacist who participates in the network plan of the 7 
hospital or medical services corporation. 8 
 2. A hospital or medical services corporation that offers or 9 
issues a policy of health insurance shall reimburse [a] : 10 
 (a) A pharmacist who participates in the network plan of the 11 
hospital or medical services corporation for the services described in 12 
NRS 639.28085 at a rate equal to the rate of reimbursement 13 
provided to a physician, physician assistant or advanced practice 14 
registered nurse for similar services. 15 
 (b) An advanced practice registered nurse or a physician 16 
assistant who participates in the network plan of the hospital or 17 
medical services corporation for any service to test for, prevent or 18 
treat human immunodeficiency virus or hepatitis C at a rate equal 19 
to the rate of reimbursement provided to a physician for similar 20 
services. 21 
 3. A hospital or medical services corporation [may subject] 22 
shall not: 23 
 (a) Subject the benefits required by subsection 1 to [reasonable] 24 
medical management techniques [.] , other than step therapy;  25 
 (b) Limit the covered amount of a drug described in paragraph 26 
(a) of subsection 1; 27 
 (c) Refuse to cover a drug described in paragraph (a) of 28 
subsection 1 because the drug is dispensed by a pharmacy through 29 
mail order service; or 30 
 (d) Prohibit or restrict access to any service or drug to treat 31 
human immunodeficiency virus or hepatitis C on the same day on 32 
which the insured is diagnosed. 33 
 4. A hospital or medical services corporation shall ensure that 34 
the benefits required by subsection 1 are made available to an 35 
insured through a provider of health care who participates in the 36 
network plan of the hospital or medical services corporation. 37 
 5. A policy of health insurance subject to the provisions of this 38 
chapter that is delivered, issued for delivery or renewed on or after 39 
[October] January 1, [2021,] 2024, has the legal effect of including 40 
the coverage required by subsection 1, and any provision of the 41 
policy that conflicts with the provisions of this section is void. 42 
 6. As used in this section: 43 
 (a) “Medical management technique” means a practice which is 44 
used to control the cost or use of health care services or prescription 45   
 	– 64 – 
 
 
- 	*SB439* 
drugs. The term includes, without limitation, the use of step therapy, 1 
prior authorization and categorizing drugs and devices based on 2 
cost, type or method of administration. 3 
 (b) “Network plan” means a policy of health insurance offered 4 
by a hospital or medical services corporation under which the 5 
financing and delivery of medical care, including items and services 6 
paid for as medical care, are provided, in whole or in part, through a 7 
defined set of providers under contract with the hospital or medical 8 
services corporation. The term does not include an arrangement for 9 
the financing of premiums. 10 
 (c) “Primary care” means the practice of family medicine, 11 
pediatrics, internal medicine, obstetrics and gynecology and 12 
midwifery.  13 
 (d) “Provider of health care” has the meaning ascribed to it in 14 
NRS 629.031. 15 
 Sec. 63.  Chapter 695C of NRS is hereby amended by adding 16 
thereto the provisions set forth as sections 64, 65 and 66 of this act. 17 
 Sec. 64.  1. A health maintenance organization that offers 18 
or issues a health care plan shall include in the plan coverage for: 19 
 (a) All drugs approved by the United States Food and Drug 20 
Administration to: 21 
  (1) Provide medication-assisted treatment for opioid use 22 
disorder, including, without limitation, buprenorphine, methadone 23 
and naltrexone. 24 
  (2) Support safe withdrawal from substance use disorder, 25 
including, without limitation, lofexidine. 26 
 (b) Any service for the treatment of substance use disorder 27 
provided by a provider of primary care if the service is covered 28 
when provided by a specialist and: 29 
  (1) The service is within the scope of practice of the 30 
provider of primary care; or  31 
  (2) The provider of primary care is capable of providing the 32 
service safely and effectively in consultation with a specialist and 33 
the provider engages in such consultation. 34 
 2. A health maintenance organization shall provide the 35 
coverage required by paragraph (a) of subsection 1 regardless of 36 
whether the drug is included in the formulary of the health 37 
maintenance organization. 38 
 3. A health maintenance organization shall not: 39 
 (a) Subject the benefits required by paragraph (a) of 40 
subsection 1 to medical management techniques, other than step 41 
therapy;  42 
 (b) Limit the covered amount of a drug described in paragraph 43 
(a) of subsection 1; or 44   
 	– 65 – 
 
 
- 	*SB439* 
 (c) Refuse to cover a drug described in paragraph (a) of 1 
subsection 1 because the drug is dispensed by a pharmacy through 2 
mail order service. 3 
 4. A health maintenance organization shall ensure that the 4 
benefits required by subsection 1 are made available to an enrollee 5 
through a provider of health care who participates in the network 6 
plan of the health maintenance organization.  7 
 5.  A health care plan subject to the provisions of this chapter 8 
that is delivered, issued for delivery or renewed on or after 9 
January 1, 2024, has the legal effect of including the coverage 10 
required by subsection 1, and any provision of the plan that 11 
conflicts with the provisions of this section is void.  12 
 6. As used in this section:  13 
 (a) “Medical management technique” means a practice which 14 
is used to control the cost or use of health care services or 15 
prescription drugs. The term includes, without limitation, the use 16 
of step therapy, prior authorization and categorizing drugs and 17 
devices based on cost, type or method of administration. 18 
 (b) “Network plan” means a health care plan offered by a 19 
health maintenance organization under which the financing and 20 
delivery of medical care, including items and services paid for as 21 
medical care, are provided, in whole or in part, through a defined 22 
set of providers under contract with the health maintenance 23 
organization. The term does not include an arrangement for the 24 
financing of premiums.  25 
 (c) “Primary care” means the practice of family medicine, 26 
pediatrics, internal medicine, obstetrics and gynecology and 27 
midwifery.  28 
 (d) “Provider of health care” has the meaning ascribed to it in 29 
NRS 629.031. 30 
 Sec. 65.  1. A health maintenance organization that offers 31 
or issues a health care plan shall include in the plan: 32 
 (a) Coverage of testing for and the treatment and prevention of 33 
sexually transmitted diseases, including, without limitation, 34 
Chlamydia trachomatis, gonorrhea, syphilis, human 35 
immunodeficiency virus and hepatitis B and C, for all enrollees, 36 
regardless of age. Such coverage must include, without limitation, 37 
the coverage required by NRS 695C.1737 and 695C.1743. 38 
 (b) Unrestricted coverage of condoms for enrollees who are 13 39 
years of age or older. 40 
 2. A health care plan subject to the provisions of this chapter 41 
that is delivered, issued for delivery or renewed on or after 42 
January 1, 2024, has the legal effect of including the coverage 43 
required by subsection 1, and any provision of the plan that 44 
conflicts with the provisions of this section is void.  45   
 	– 66 – 
 
 
- 	*SB439* 
 Sec. 66.  1. A health care plan which provides coverage for 1 
prescription drugs must provide that, when calculating the amount 2 
of the contribution by an enrollee towards a deductible, 3 
copayment, coinsurance or any other cost-sharing requirement for 4 
prescription drugs, the health maintenance organization or any 5 
pharmacy benefit manager that manages pharmacy benefits for 6 
the health maintenance organization must include the amount 7 
paid by the enrollee or another person or entity on behalf of the 8 
enrollee for a prescription drug: 9 
 (a) That has no generic equivalent;  10 
 (b) For which the health maintenance organization or 11 
pharmacy benefit manager has imposed a requirement for prior 12 
authorization or a step therapy protocol;  13 
 (c) Which is only covered under the health care plan after the 14 
enrollee: 15 
  (1) Obtains an exception to a general policy of the health 16 
maintenance organization or pharmacy benefit manager; or  17 
  (2) Wins an appeal of such a policy; or 18 
 (d) That is prescribed to: 19 
  (1) Prevent the acquisition of human immunodeficiency 20 
virus; 21 
  (2) Treat human immunodeficiency virus or hepatitis C; 22 
  (3) Provide medication-assisted treatment for opioid use 23 
disorder; or 24 
  (4) Support safe withdrawal from substance use disorder. 25 
 2. A health care plan subject to the provisions of this chapter 26 
that is delivered, issued for delivery or renewed on or after 27 
January 1, 2024, has the legal effect of including the provisions 28 
required by subsection 1, and any provision of the plan that 29 
conflicts with the provisions of this section is void.  30 
 3. As used in this section, “pharmacy benefit manager” has 31 
the meaning ascribed to it in NRS 683A.174. 32 
 Sec. 67.  NRS 695C.050 is hereby amended to read as follows: 33 
 695C.050 1.  Except as otherwise provided in this chapter or 34 
in specific provisions of this title, the provisions of this title are not 35 
applicable to any health maintenance organization granted a 36 
certificate of authority under this chapter. This provision does not 37 
apply to an insurer licensed and regulated pursuant to this title 38 
except with respect to its activities as a health maintenance 39 
organization authorized and regulated pursuant to this chapter. 40 
 2.  Solicitation of enrollees by a health maintenance 41 
organization granted a certificate of authority, or its representatives, 42 
must not be construed to violate any provision of law relating to 43 
solicitation or advertising by practitioners of a healing art. 44   
 	– 67 – 
 
 
- 	*SB439* 
 3.  Any health maintenance organization authorized under this 1 
chapter shall not be deemed to be practicing medicine and is exempt 2 
from the provisions of chapter 630 of NRS. 3 
 4.  The provisions of NRS 695C.110, 695C.125, 695C.1691, 4 
695C.1693, 695C.170, 695C.1703, 695C.1705, 695C.1709 to 5 
695C.173, inclusive, 695C.1733, 695C.17335, 695C.1734, 6 
695C.1751, 695C.1755, 695C.1759, 695C.176 to 695C.200, 7 
inclusive, and 695C.265 do not apply to a health maintenance 8 
organization that provides health care services through managed 9 
care to recipients of Medicaid under the State Plan for Medicaid or 10 
insurance pursuant to the Children’s Health Insurance Program 11 
pursuant to a contract with the Division of Health Care Financing 12 
and Policy of the Department of Health and Human Services. This 13 
subsection does not exempt a health maintenance organization from 14 
any provision of this chapter for services provided pursuant to any 15 
other contract. 16 
 5.  The provisions of NRS 695C.1694 to 695C.1698, inclusive, 17 
695C.1701, 695C.1708, 695C.1728, 695C.1731, 695C.17333, 18 
695C.17345, 695C.17347, 695C.1735, 695C.1737, 695C.1743, 19 
695C.1745 and 695C.1757 and sections 64, 65 and 66 of this act 20 
apply to a health maintenance organization that provides health care 21 
services through managed care to recipients of Medicaid under the 22 
State Plan for Medicaid. 23 
 Sec. 68.  NRS 695C.1743 is hereby amended to read as 24 
follows: 25 
 695C.1743 1. A health maintenance organization that offers 26 
or issues a health care plan shall include in the plan coverage for:  27 
 (a) [Drugs] All drugs approved by the United States Food and 28 
Drug Administration for preventing the acquisition of human 29 
immunodeficiency virus [;] or treating human immunodeficiency 30 
virus or hepatitis C in the form recommended by the prescribing 31 
practitioner, regardless of whether the drug is included in the 32 
formulary of the health maintenance organization; 33 
 (b) Laboratory testing that is necessary for therapy that uses 34 
[such] a drug [;] to prevent the acquisition of human 35 
immunodeficiency virus;  36 
 (c) Any service to test for, prevent or treat human 37 
immunodeficiency virus or hepatitis C provided by a provider of 38 
primary care if the service is covered when provided by a specialist 39 
and: 40 
  (1) The service is within the scope of practice of the 41 
provider of primary care; or  42 
  (2) The provider of primary care is capable of providing the 43 
service safely and effectively in consultation with a specialist and 44 
the provider engages in such consultation; and  45   
 	– 68 – 
 
 
- 	*SB439* 
 [(c)] (d) The services described in NRS 639.28085, when 1 
provided by a pharmacist who participates in the network plan of the 2 
health maintenance organization.  3 
 2. A health maintenance organization that offers or issues a 4 
health care plan shall reimburse [a] : 5 
 (a) A pharmacist who participates in the network plan of the 6 
health maintenance organization for the services described in NRS 7 
639.28085 at a rate equal to the rate of reimbursement provided to a 8 
physician, physician assistant or advanced practice registered nurse 9 
for similar services.  10 
 (b) An advanced practice registered nurse or a physician 11 
assistant who participates in the network plan of the health 12 
maintenance organization for any service to test for, prevent or 13 
treat human immunodeficiency virus or hepatitis C at a rate equal 14 
to the rate of reimbursement provided to a physician for similar 15 
services. 16 
 3. A health maintenance organization [may subject] shall not: 17 
 (a) Subject the benefits required by subsection 1 to [reasonable] 18 
medical management techniques [.] , other than step therapy;  19 
 (b) Limit the covered amount of a drug described in paragraph 20 
(a) of subsection 1; 21 
 (c) Refuse to cover a drug described in paragraph (a) of 22 
subsection 1 because the drug is dispensed by a pharmacy through 23 
mail order service; or 24 
 (d) Prohibit or restrict access to any service or drug to treat 25 
human immunodeficiency virus or hepatitis C on the same day on 26 
which the enrollee is diagnosed. 27 
 4. A health maintenance organization shall ensure that the 28 
benefits required by subsection 1 are made available to an enrollee 29 
through a provider of health care who participates in the network 30 
plan of the health maintenance organization.  31 
 5. A health care plan subject to the provisions of this chapter 32 
that is delivered, issued for delivery or renewed on or after 33 
[October] January 1, [2021,] 2024, has the legal effect of including 34 
the coverage required by subsection 1, and any provision of the plan 35 
that conflicts with the provisions of this section is void.  36 
 6. As used in this section:  37 
 (a) “Medical management technique” means a practice which is 38 
used to control the cost or use of health care services or prescription 39 
drugs. The term includes, without limitation, the use of step therapy, 40 
prior authorization and categorizing drugs and devices based on 41 
cost, type or method of administration. 42 
 (b) “Network plan” means a health care plan offered by a health 43 
maintenance organization under which the financing and delivery of 44 
medical care, including items and services paid for as medical care, 45   
 	– 69 – 
 
 
- 	*SB439* 
are provided, in whole or in part, through a defined set of providers 1 
under contract with the health maintenance organization. The term 2 
does not include an arrangement for the financing of premiums.  3 
 (c) “Primary care” means the practice of family medicine, 4 
pediatrics, internal medicine, obstetrics and gynecology and 5 
midwifery. 6 
 (d) “Provider of health care” has the meaning ascribed to it in 7 
NRS 629.031. 8 
 Sec. 69.  NRS 695C.330 is hereby amended to read as follows: 9 
 695C.330 1.  The Commissioner may suspend or revoke any 10 
certificate of authority issued to a health maintenance organization 11 
pursuant to the provisions of this chapter if the Commissioner finds 12 
that any of the following conditions exist: 13 
 (a) The health maintenance organization is operating 14 
significantly in contravention of its basic organizational document, 15 
its health care plan or in a manner contrary to that described in and 16 
reasonably inferred from any other information submitted pursuant 17 
to NRS 695C.060, 695C.070 and 695C.140, unless any amendments 18 
to those submissions have been filed with and approved by the 19 
Commissioner; 20 
 (b) The health maintenance organization issues evidence of 21 
coverage or uses a schedule of charges for health care services 22 
which do not comply with the requirements of NRS 695C.1691 to 23 
695C.200, inclusive, and sections 64, 65 and 66 of this act or 24 
695C.207; 25 
 (c) The health care plan does not furnish comprehensive health 26 
care services as provided for in NRS 695C.060; 27 
 (d) The Commissioner certifies that the health maintenance 28 
organization: 29 
  (1) Does not meet the requirements of subsection 1 of NRS 30 
695C.080; or 31 
  (2) Is unable to fulfill its obligations to furnish health care 32 
services as required under its health care plan; 33 
 (e) The health maintenance organization is no longer financially 34 
responsible and may reasonably be expected to be unable to meet its 35 
obligations to enrollees or prospective enrollees; 36 
 (f) The health maintenance organization has failed to put into 37 
effect a mechanism affording the enrollees an opportunity to 38 
participate in matters relating to the content of programs pursuant to 39 
NRS 695C.110; 40 
 (g) The health maintenance organization has failed to put into 41 
effect the system required by NRS 695C.260 for: 42 
  (1) Resolving complaints in a manner reasonably to dispose 43 
of valid complaints; and 44   
 	– 70 – 
 
 
- 	*SB439* 
  (2) Conducting external reviews of adverse determinations 1 
that comply with the provisions of NRS 695G.241 to 695G.310, 2 
inclusive; 3 
 (h) The health maintenance organization or any person on its 4 
behalf has advertised or merchandised its services in an untrue, 5 
misrepresentative, misleading, deceptive or unfair manner; 6 
 (i) The continued operation of the health maintenance 7 
organization would be hazardous to its enrollees or creditors or to 8 
the general public; 9 
 (j) The health maintenance organization fails to provide the 10 
coverage required by NRS 695C.1691; or 11 
 (k) The health maintenance organization has otherwise failed to 12 
comply substantially with the provisions of this chapter. 13 
 2.  A certificate of authority must be suspended or revoked only 14 
after compliance with the requirements of NRS 695C.340. 15 
 3.  If the certificate of authority of a health maintenance 16 
organization is suspended, the health maintenance organization shall 17 
not, during the period of that suspension, enroll any additional 18 
groups or new individual contracts, unless those groups or persons 19 
were contracted for before the date of suspension. 20 
 4.  If the certificate of authority of a health maintenance 21 
organization is revoked, the organization shall proceed, immediately 22 
following the effective date of the order of revocation, to wind up its 23 
affairs and shall conduct no further business except as may be 24 
essential to the orderly conclusion of the affairs of the organization. 25 
It shall engage in no further advertising or solicitation of any kind. 26 
The Commissioner may, by written order, permit such further 27 
operation of the organization as the Commissioner may find to be in 28 
the best interest of enrollees to the end that enrollees are afforded 29 
the greatest practical opportunity to obtain continuing coverage for 30 
health care. 31 
 Sec. 70.  Chapter 695G of NRS is hereby amended by adding 32 
thereto the provisions set forth as sections 71, 72 and 73 of this act. 33 
 Sec. 71.  1. A managed care organization that offers or 34 
issues a health care plan shall include in the plan coverage for: 35 
 (a) All drugs approved by the United States Food and Drug 36 
Administration to: 37 
  (1) Provide medication-assisted treatment for opioid use 38 
disorder, including, without limitation, buprenorphine, methadone 39 
and naltrexone. 40 
  (2) Support safe withdrawal from substance use disorder, 41 
including, without limitation, lofexidine. 42 
 (b) Any service for the treatment of substance use disorder 43 
provided by a provider of primary care if the service is covered 44 
when provided by a specialist and: 45   
 	– 71 – 
 
 
- 	*SB439* 
  (1) The service is within the scope of practice of the 1 
provider of primary care; or  2 
  (2) The provider of primary care is capable of providing the 3 
service safely and effectively in consultation with a specialist and 4 
the provider engages in such consultation. 5 
 2. A managed care organization shall provide the coverage 6 
required by paragraph (a) of subsection 1 regardless of whether 7 
the drug is included in the formulary of the managed care 8 
organization. 9 
 3. A managed care organization shall not: 10 
 (a) Subject the benefits required by paragraph (a) of 11 
subsection 1 to medical management techniques, other than step 12 
therapy;  13 
 (b) Limit the covered amount of a drug described in paragraph 14 
(a) of subsection 1; or 15 
 (c) Refuse to cover a drug described in paragraph (a) of 16 
subsection 1 because the drug is dispensed by a pharmacy through 17 
mail order service. 18 
 4. A managed care organization shall ensure that the benefits 19 
required by subsection 1 are made available to an insured through 20 
a provider of health care who participates in the network plan of 21 
the managed care organization. 22 
 5.  A health care plan subject to the provisions of this chapter 23 
that is delivered, issued for delivery or renewed on or after 24 
January 1, 2024, has the legal effect of including the coverage 25 
required by subsection 1, and any provision of the plan that 26 
conflicts with the provisions of this section is void.  27 
 6. As used in this section:  28 
 (a) “Medical management technique” means a practice which 29 
is used to control the cost or use of health care services or 30 
prescription drugs. The term includes, without limitation, the use 31 
of step therapy, prior authorization and categorizing drugs and 32 
devices based on cost, type or method of administration. 33 
 (b) “Network plan” means a health care plan offered by a 34 
managed care organization under which the financing and 35 
delivery of medical care, including items and services paid for as 36 
medical care, are provided, in whole or in part, through a defined 37 
set of providers under contract with the managed care 38 
organization. The term does not include an arrangement for the 39 
financing of premiums.  40 
 (c) “Primary care” means the practice of family medicine, 41 
pediatrics, internal medicine, obstetrics and gynecology and 42 
midwifery.  43 
 (d) “Provider of health care” has the meaning ascribed to it in 44 
NRS 629.031. 45   
 	– 72 – 
 
 
- 	*SB439* 
 Sec. 72.  1. A managed care organization that offers or 1 
issues a health care plan shall include in the plan: 2 
 (a) Coverage of testing for, treatment of and prevention of 3 
sexually transmitted diseases, including, without limitation, 4 
Chlamydia trachomatis, gonorrhea, syphilis, human 5 
immunodeficiency virus and hepatitis B and C, for all insureds, 6 
regardless of age. Such coverage must include, without limitation, 7 
the coverage required by NRS 695G.1705 and 695G.1714. 8 
 (b) Unrestricted coverage of condoms for insureds who are 13 9 
years of age or older. 10 
 2. A health care plan subject to the provisions of this chapter 11 
that is delivered, issued for delivery or renewed on or after 12 
January 1, 2024, has the legal effect of including the coverage 13 
required by subsection 1, and any provision of the plan that 14 
conflicts with the provisions of this section is void.  15 
 Sec. 73.  1. A health care plan which provides coverage for 16 
prescription drugs must provide that, when calculating the amount 17 
of the contribution by an insured towards a deductible, copayment, 18 
coinsurance or any other cost-sharing requirement for 19 
prescription drugs, the managed care organization or any 20 
pharmacy benefit manager that manages pharmacy benefits for 21 
the managed care organization must include the amount paid by 22 
the insured or another person or entity on behalf of the insured 23 
for a prescription drug: 24 
 (a) That has no generic equivalent;  25 
 (b) For which the managed care organization or pharmacy 26 
benefit manager has imposed a requirement for prior 27 
authorization or a step therapy protocol; 28 
 (c) Which is only covered under the health care plan after the 29 
insured: 30 
  (1) Obtains an exception to a general policy of the managed 31 
care organization or pharmacy benefit manager; or  32 
  (2) Wins an appeal of such a policy; or 33 
 (d) That is prescribed to: 34 
  (1) Prevent the acquisition of human immunodeficiency 35 
virus; 36 
  (2) Treat human immunodeficiency virus or hepatitis C; 37 
  (3) Provide medication-assisted treatment for opioid use 38 
disorder; or 39 
  (4) Support safe withdrawal from substance use disorder. 40 
 2. A health care plan subject to the provisions of this chapter 41 
that is delivered, issued for delivery or renewed on or after 42 
January 1, 2024, has the legal effect of including the provisions 43 
required by subsection 1, and any provision of the plan that 44 
conflicts with the provisions of this section is void.  45   
 	– 73 – 
 
 
- 	*SB439* 
 3. As used in this section, “pharmacy benefit manager” has 1 
the meaning ascribed to it in NRS 683A.174. 2 
 Sec. 74.  NRS 695G.1705 is hereby amended to read as 3 
follows: 4 
 695G.1705 1. A managed care organization that offers or 5 
issues a health care plan shall include in the plan coverage for:  6 
 (a) [Drugs] All drugs approved by the United States Food and 7 
Drug Administration for preventing the acquisition of human 8 
immunodeficiency virus [;] or treating human immunodeficiency 9 
virus or hepatitis C in the form recommended by the prescribing 10 
practitioner, regardless of whether the drug is included in the 11 
formulary of the managed care organization; 12 
 (b) Laboratory testing that is necessary for therapy that uses 13 
[such] a drug [;] to prevent the acquisition of human 14 
immunodeficiency virus;  15 
 (c) Any service to test for, prevent or treat human 16 
immunodeficiency virus or hepatitis C provided by a provider of 17 
primary care if the service is covered when provided by a specialist 18 
and: 19 
  (1) The service is within the scope of practice of the 20 
provider of primary care; or  21 
  (2) The provider of primary care is capable of providing the 22 
service safely and effectively in consultation with a specialist and 23 
the provider engages in such consultation; and  24 
 [(c)] (d) The services described in NRS 639.28085, when 25 
provided by a pharmacist who participates in the network plan of the 26 
managed care organization.  27 
 2. A managed care organization that offers or issues a health 28 
care plan shall reimburse [a] : 29 
 (a) A pharmacist who participates in the network plan of the 30 
managed care organization for the services described in NRS 31 
639.28085 at a rate equal to the rate of reimbursement provided to a 32 
physician, physician assistant or advanced practice registered nurse 33 
for similar services.  34 
 (b) An advanced practice registered nurse or a physician 35 
assistant who participates in the network plan of the managed care 36 
organization for any service to test for, prevent or treat human 37 
immunodeficiency virus or hepatitis C at a rate equal to the rate of 38 
reimbursement provided to a physician for similar services. 39 
 3. A managed care organization [may subject] shall not: 40 
 (a) Subject the benefits required by subsection 1 to [reasonable] 41 
medical management techniques [.] , other than step therapy;  42 
 (b) Limit the covered amount of a drug described in paragraph 43 
(a) of subsection 1; 44   
 	– 74 – 
 
 
- 	*SB439* 
 (c) Refuse to cover a drug described in paragraph (a) of 1 
subsection 1 because the drug is dispensed by a pharmacy through 2 
mail order service; or 3 
 (d) Prohibit or restrict access to any service or drug to treat 4 
human immunodeficiency virus or hepatitis C on the same day on 5 
which the insured is diagnosed. 6 
 4. A managed care organization shall ensure that the benefits 7 
required by subsection 1 are made available to an insured through a 8 
provider of health care who participates in the network plan of the 9 
managed care organization.  10 
 5. A health care plan subject to the provisions of this chapter 11 
that is delivered, issued for delivery or renewed on or after 12 
[October] January 1, [2021,] 2024, has the legal effect of including 13 
the coverage required by subsection 1, and any provision of the plan 14 
that conflicts with the provisions of this section is void.  15 
 6. As used in this section:  16 
 (a) “Medical management technique” means a practice which is 17 
used to control the cost or use of health care services or prescription 18 
drugs. The term includes, without limitation, the use of step therapy, 19 
prior authorization and categorizing drugs and devices based on 20 
cost, type or method of administration. 21 
 (b) “Network plan” means a health care plan offered by a 22 
managed care organization under which the financing and delivery 23 
of medical care, including items and services paid for as medical 24 
care, are provided, in whole or in part, through a defined set of 25 
providers under contract with the managed care organization. The 26 
term does not include an arrangement for the financing of 27 
premiums.  28 
 (c) “Primary care” means the practice of family medicine, 29 
pediatrics, internal medicine, obstetrics and gynecology and 30 
midwifery.  31 
 (d) “Provider of health care” has the meaning ascribed to it in 32 
NRS 629.031. 33 
Sec. 75.  1. The first application that a physician, osteopathic 34 
physician or physician assistant licensed pursuant to chapter 630 or 35 
633 of NRS or a nurse who provides or supervises the provision of 36 
emergency medical services in a hospital or primary care and who is 37 
licensed on January 1, 2024, submits to renew his or her license on 38 
or after that date must include, without limitation, proof that the 39 
applicant has completed at least 2 hours of training in the stigma, 40 
discrimination and unrecognized bias toward persons who have 41 
acquired or are at a high risk of acquiring human immunodeficiency 42 
virus, as required by NRS 630.253, 632.343 and 633.471, as 43 
amended by sections 28, 29 and 30 of this act, respectively, as 44 
applicable. 45   
 	– 75 – 
 
 
- 	*SB439* 
 2. As used in this section, “primary care” means the practice of 1 
family medicine, pediatrics, internal medicine, obstetrics and 2 
gynecology and midwifery.  3 
 Sec. 76.  The Legislature hereby finds and declares that:  4 
 1. In Lapinski v. State, 84 Nev. 611, 613 (1968), the Nevada 5 
Supreme Court held that “the power to define crimes and penalties 6 
lies exclusively in the legislature.”  7 
 2. The Nevada Supreme Court has further held in Tellis v. 8 
State, 84 Nev. 587, 591 (1968), Sparkman v. State, 95 Nev. 76, 82 9 
(1979) and State v. Dist. Ct. (Pullin), 124 Nev. 564, 567-68 (2008), 10 
that the penalty for a crime is determined by the law in effect at the 11 
time the offender committed the crime and not the law in effect at 12 
the time the offender is sentenced unless the Legislature has 13 
expressed its clear intent that a statute ameliorating the penalty 14 
apply retroactively.  15 
 3. NRS 441A.118 states that “[t]he Legislature hereby finds 16 
and declares that the spread of communicable diseases is best 17 
addressed through public health measures rather than 18 
criminalization.” 19 
 4. For those reasons, the Legislature is exercising its exclusive 20 
power to define the acts which subject a person to criminal penalties 21 
by: 22 
 (a) Retroactively applying the provisions of section 24 of 23 
chapter 491, Statutes of Nevada 2021, at page 3199, which repealed 24 
certain criminal offenses that were based on a person having the 25 
human immunodeficiency virus, to apply to conduct that occurred 26 
before those offenses were repealed; and 27 
 (b) Making certain offenses which were punishable as category 28 
A felonies before the effective date of section 13 of this act based on 29 
the potential to spread a communicable disease instead punishable 30 
as category B felonies, category D felonies or gross misdemeanors.  31 
 Sec. 77.  1. The provisions of section 24 of chapter 491, 32 
Statutes of Nevada 2021, at page 3199, apply to any violation of 33 
NRS 201.205 or 201.358, as those sections existed before the 34 
enactment of section 24 of chapter 491, Statutes of Nevada 2021, at 35 
page 3199, if the violation occurred before, on or after June 6, 2021, 36 
and the person was convicted on or after the effective date of this 37 
section. 38 
 2. The provisions of section 3 of this act apply to any violation 39 
of NRS 201.205 or 201.358, as those sections existed before the 40 
enactment of section 24 of chapter 491, Statutes of Nevada 2021, at 41 
page 3199, if the violation occurred before, on or after June 6, 2021, 42 
regardless of when the person was convicted.  43 
 3. If, before June 6, 2021, a person committed a violation of a 44 
NRS 201.205 or 201.358, as those sections existed before the 45   
 	– 76 – 
 
 
- 	*SB439* 
enactment of section 24 of chapter 491, Statutes of Nevada 2021, at 1 
page 3199, and the person was not charged for that violation before 2 
the effective date of this section, the person must not be charged for 3 
that violation. 4 
 4. Each court in this State shall cancel each outstanding bench 5 
warrant issued by the court for a person who failed to appear in 6 
court in relation to an alleged violation of NRS 201.205 or 201.358, 7 
as those sections existed before the enactment of section 24 of 8 
chapter 491, Statutes of Nevada 2021, at page 3199. 9 
 5. The Central Repository for Nevada Records of Criminal 10 
History shall remove from each database or compilation of records 11 
of criminal history maintained by the Central Repository all records 12 
of bench warrants issued for a person who failed to appear in court 13 
in relation to an alleged violation of NRS 201.205 or 201.358, as 14 
those sections existed before the enactment of section 24 of chapter 15 
491, Statutes of Nevada 2021, at page 3199. 16 
 Sec. 78.  1. The provisions of NRS 212.189, as amended by 17 
section 13 of this act, apply to any violation of that section, that 18 
occurred before, on or after the effective date of that section, if the 19 
person was not convicted before the effective date of that section. 20 
 2. If a person commits a violation of a NRS 212.189 which is 21 
punishable as a category A felony before the effective date of 22 
section 13 of this act, and the violation is punishable as a category B 23 
felony, a category D felony or a gross misdemeanor pursuant to 24 
NRS 212.189, as amended by section 13 of this act, the person must 25 
not be charged with or convicted of a category A felony, if the 26 
violation occurs on or after the effective date of section 13 of this 27 
act, and may only be charged with and convicted of a category B 28 
felony, category D felony or gross misdemeanor, as applicable, on 29 
or after the effective date of section 13 of this act.  30 
 Sec. 79.  The provisions of NRS 354.599 do not apply to any 31 
additional expenses of a local government that are related to the 32 
provisions of this act. 33 
 Sec. 80.  1. This section and sections 3 to 10, inclusive, 13, 34 
76, 77 and 78 of this act become effective upon passage and 35 
approval. 36 
 2. Sections 1, 2, 11, 12, 14 to 75, inclusive, and 79 of this act 37 
become effective: 38 
 (a) Upon passage and approval for the purpose of adopting any 39 
regulations and performing any other preparatory administrative 40 
tasks that are necessary to carry out the provisions of this act; and 41 
 (b) On January 1, 2024, for all other purposes. 42 
 
H